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Abstract 
JUN ZHANG: Structure and dynamics of the MAGUK core of PSD-95 
 
(Under the direction of Andrew L. Lee) 
 Protein allostery plays central roles in regulation of enzyme catalysis, signaling 
conduction and cellular metabolism. In this research, the interdomain allostery of 
postsynaptic density protein 95 (PSD-95), a key component of the postsynapse, was 
studied using NMR and other biophysical methods. Previous research has identified 
numerous PSD-95 interaction partners and revealed many PSD-95 mediated biological 
functions. Interestingly, interdomain allostery within PSD-95 has been found between 
PDZ3 and the following SH3/GK, and these allosteric events are regulated by 
phosphorylation. However, the structural mechanism of interdomain allostery and 
phosphorylation regulation is not addressed by in vivo studies on biological functions or 
in vitro studies on excised domains. In this dissertation, we studied the structural and 
dynamic effects of phosphorylation at the PDZ3/SH3 linker (Y397, S415 and S418). 
Upon phosphorylation, we found that the C-extension α-helix of PDZ3 is unfolded and 
undocked. We further examined the PDZ3-SH3 construct and showed that 
phosphorylation interrupts the domain interaction between PDZ3 and SH3. Using 
chemical shift perturbation and paramagnetic relaxation enhancement, we identified the 
PDZ3-SH3 interface. These experiments also suggested that CRIPT binding moves PDZ3 
away from SH3. To understand interdomain allostery, we modeled the PDZ3-SH3-GK 
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structure using SAXS. Consistent with PRE results, we found PDZ3 is mainly docked to 
the Hook domain region of the SH3 domain, and CRIPT binding reshuffles the domain 
packing between PDZ3 and SH3-GK. To obtain a high resolution structural model of 
PDZ3-SH3-GK, we carried out Rosetta simulations in the presence of PRE and chemical 
shift perturbation constraints. We found that the PDZ3 domain uses its peptide binding 
groove to interact with the PDZ3-SH3 linker. This interaction brings PDZ3 close to SH3, 
whereas it can be disrupted by CRIPT binding. This Rosetta model also reveals that the 
positively charged face of the Hook domain, which is the binding interface for 
calmodulin, is masked by the PDZ3 domain. Therefore the model provides a basis for 
understanding interdomain allostery between SH3 and PDZ3. In this research we also 
discussed the possible mechanism by which PDZ3 and GK allostery is transferred. 
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Chapter 1 
Introduction 
 
Proteins are involved in nearly all biological processes. Studying protein function 
therefore lays the basis for understanding biological phenomena. Traditionally, protein 
structure is deemed to be most important in deciphering protein function at the atomic 
level. Indeed, the last several decades have witnessed an intense focus on protein 
structure, as demonstrated by over 70,000 deposited protein structures in Protein Data 
Bank; The last several decades have also witnessed dramatic progress in and great benefit 
from studies on protein structure: by studying protein structure, we understand how 
proteins function as enzymes, how proteins interact to transduce signals, how proteins are 
regulated in aspects of the synthesis, function and destination, and how novel proteins 
can be designed to possess functions of our interests.  
 Despite being insightful and powerful, studying protein structure does not provide 
a complete understanding of protein function. For example, it has been found that many 
eukaryotic proteins exist and function as intrinsically disordered proteins (IDPs). These 
proteins lack well defined structures, or are only transiently structured. The existence of 
IDPs can only be explained by inter-converting ensembles [1-3]. Actually, even for a 
protein with stable structure, its function cannot be fully recapitulated by its static protein 
structure alone. Another important property encoded in the primary sequence is protein 
dynamics. The dynamics here is referred to as the coordinate changes of protein atoms at 
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various time scales ranging from picoseconds (ps) to seconds. In essence, nearly all 
biological processes are ever exchanging, which requires proteins to possess dynamic 
properties. Numerous studies have proven that protein dynamics plays important roles in 
enzyme catalysis[1], ligand binding [2, 3], and allostery transferring and regulation [4]. 
This thesis aims to understand interdomain allostery of postsynapse density 
protein 95 (PSD-95) from structural and dynamic aspects. PSD-95 consists of three PDZ 
domains, an SH3 domain and a non-catalytic GK domain. Recent studies have shown that 
interdomain communication is present in PSD-95. Especially, the PDZ domains of PSD-
95 possess active roles more than scaffolds, as suggested by allosteric interaction of the 
PDZ domains with other domain components. Because of central importance of the PDZ 
domains for this project, the general features of PDZ domains will be introduced in the 
following section.    
1.1 Introduction to PDZ domains 
 
PDZ domains are named after the postsynaptic density protein-95 (PSD-95), 
drosophila Discs large tumor suppressor, and zonula occludens-1 protein (Zo-1), which 
were the first three proteins found to share the domain. Following studies suggested that 
PDZ domains are ubiquitously found in bacteria, yeast, plants, viruses and animals [5]. In 
human beings, over 200 PDZ containing proteins have been identified [6, 7], most of 
which are signaling proteins. Usually PDZ domains occur with other protein interacting 
domains, such as SH3 and L27 [8]. 
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Figure 1.1: The representative structure of PDZ domains. The binding groove formed by α2 and β2 are 
denoted. The binding peptide (-QTSV) is shown in green sticks. The H-bonds between the PDZ domain 
and the peptide are shown in green dotted lines. The third α-helix, which is usually not deemed as a 
canonical element of PDZ domain, is shown in gray. The graphic was prepared based on the crystal 
structure of PSD-95 PDZ3 (PDB ID 1BE9) using PyMol. 
 
The first solved crystal structure of a PDZ domain is the third PDZ domain (PDZ3) 
of PSD-95 by Doyle et al.[9]. As shown in Fig. 1.1, PDZ3 is folded into a compact 
globular structure, consisting of six β strands and two α-helices. Β2 and α2 form a 
peptide binding groove. With more PDZ domains identified and more homologue 
structures solved, the PDZ fold paradigm established by PSD-95 PDZ3 was confirmed 
again and again, though the homology of primary amino acid sequence of PDZ domain 
can be as low as 20 %.  
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PDZ domains are protein interacting modules. The basic function of a PDZ domain 
is to cluster various signaling proteins to facilitate protein interaction among target 
proteins. This may explain why PDZ domains occur multiple times in the same protein or 
along with other protein interacting modules. PDZ domains fulfill their recruitment role 
through binding the C-termini of target proteins. The recognition sequence contains 
approximately 4-7 amino acids. According to the sequence consensus of PDZ binding 
peptides, PDZ domains, as well as PDZ binding peptides, are cataloged into three classes: 
-(S/T) XФ (Class I), - (Ф/Ψ) XФ (Class II) and –G (E/D) XV (Class III), where X 
corresponds to any amino acid, Ф to hydrophobic residues and Ψ to aromatic 
residues[10]. The hydrophobic sidechain of the very C-terminal residues is docked into a 
hydrophobic patch of the PDZ binding groove. The carboxyl terminal is required for most 
PDZ peptide interactions, because the carboxyl group forms H-bonds with PDZ domain. 
There are exceptions to this. For example, syntrophin PDZ domain can also bind to 
internal fragments of target proteins [11]. A more systematic study suggested that PDZ 
domains are able to bind internal peptides, provided that the internal peptides can adopt 
into correct conformations for recognition [12].   
 The specific function of a PDZ domain can only be fully understood in the 
context of the full length PDZ bearing protein, despite the fact that an isolated PDZ 
domain and its target peptides may be well characterized. That means the particular 
function of a PDZ domain also depends on other domains present in the same protein. In 
reality, rarely does a PDZ domain alone constitute a single domain protein. Instead, PDZ 
domains are integrated into protein multiple times, or with other domains[13]. The 
domains other than PDZ may determine the location of the PDZ containing protein, the 
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components of signal complex or pathways involved. This is a straightforward reason 
why PDZ function is context dependent.  
 Ten years after the first reported structure of PDZ domains, these domains are 
found to interplay with other domains, more than just passive scaffolding. This 
interdomain allostery has been found in several PDZ containing proteins. The 
conformation of the PDZ domain from Par 6 changes upon interaction between CRIB and 
CDC42. CRIB is adjacent to the PDZ domain in Par 6, and forms a domain packing 
interface, which transfer the interdomain allostery [14]. Interdomain interaction is also 
exemplified by PDZ4/PDZ5 from GRIP [15], in which PDZ4 and PDZ5 domain are 
mutually dependent. The presence of one domain is indispensible for the correct folding 
and stability of the other domain. These cases of interdomain allostery pose a challenge 
to the traditional consideration of PDZ domain as simple modular binding domain.  
1.2 PSD-95 
 
Postsynaptic density protein 95 (PSD-95) is one of the most abundant proteins in 
postsynapse, which is the key component of neuron signal transduction apparatus [16, 17]. 
The known functions of PSD-95 established by existing research include postsynapse 
genesis, stability and strength, ion channel clustering and localization, signal complex 
organization [7, 16]. The functional mechanism of PSD-95 is still unclear. Malfunction or 
deficiency of PSD-95 was shown to result in impaired learning and memory [7, 16]. 
Recent studies suggested that PSD-95 is related to central nervous system diseases, such 
as Alzheimer’s [18, 19] and Huntington’s disease [20].   
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Palmitoylation of PSD-95 is necessary for PSD-95 clustering and neurotransmission 
mediated by AMPA receptor. 
PDZ1/PDZ2: PDZ1 and PDZ2 are connected by a short linker of 5-6 amino acids. 
The tandem PDZ1/PDZ2 structure has been solved by NMR and crystallography (Fig. 1.3) 
[22, 27]. A recent study by Wang et al. reveals that PDZ1 and PDZ2 forms an 
interdomain interface [27], and the orientation of the two domains is not random. The two 
domains are oriented in such a way that the binding grooves of PDZ1/PDZ2 are aligned, 
which makes peptide binding of two domains synergistic. Using residual dipolar coupling 
and MD simulation, Wang et al. showed that cypin peptide binding of PDZ1/PDZ2 
increased domain flexibility[22]. These results suggest PDZ1 and PDZ2 function as an 
intact functional moiety.  
 
Figure 1.3: The crystal structure of the PDZ1/PDZ2 tandem. 
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PDZ3: PDZ3 is separated from PDZ1/PDZ2 by a 50 residue linker. PDZ3 is the 
first structurally solved PDZ domain [9]. It mainly binds to Class I targets, such as APC, 
NR2B, neuroligin, CRIPT, stargazin and Kv1.4 [28]. According to crystal structures of 
PDZ3 in apo and peptide bound forms, PDZ3 does not experience conformational 
changes[9]. The absence of conformational changes upon peptide binding tends to 
impose onto PDZ3 a passive profile typical of scaffolding proteins. PDZ3 in the context 
of full length PSD-95, however, seems to possess more “active” roles, which will be 
discussed later. Although PDZ3 from PSD-95 is deemed a structure paradigm for the 
PDZ family, it is quite atypical due to the presence of a third α helix (α3) (Fig. 1.1). It 
seems it is the third α helix that endows PDZ3 with interdomain allosteric roles. The α3 
region is highly conserved throughout the MAGUK family. Deletion or replacement of 
α3 with random coil sequence in Dlg1 (a homology of PSD-95) removes the 
aforementioned interdomain allosteric behavior between SH3 and PDZ3[29]. This linker 
region between PDZ3 and SH3 is likely also a hot spot for regulation. Three 
phosphorylation sites have been identified, Y397[30], Ser415 and Ser418[31, 32]. 
Sequence alignment suggests these phosphorylation sites are quite conserved.  
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Figure 1.4: The crystal structure of the SH3-GK tandem. The SH3 domain is shown in cyan, the Hook 
domain in magentas, and the GK domain in green. The fifth and sixth β-stands are denoted and shown in 
yellow and red respectively.  
 
SH3/GK: Canonically, SH3 is a protein interacting domain which recognizes a 
PXXP motif [33, 34]. The sidechains of prolines fit into hydrophobic groove of the SH3 
domain. The SH3 domain of PSD-95 is modified by an insertion α-helix and flexible loop, 
which is called the Hook domain (Fig. 1.4)[35, 36]. The α-helix portion of the Hook 
domain is conserved throughout PSD-95, while the flexible loop shares low homology. 
Insertion of Hook domain partially occludes the PXXP binding groove. However, it was 
reported that the microtubule end-binding protein, EB3, directly interacts with SH3 using 
a proline-rich motif [37]. Several studies also suggest that the Hook domain, which is rich 
in positively charged residues, binds to calmodulin in a negatively charged groove [38, 
39].  
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The SH3 domain in PSD95 is structurally dependent on the GK domain. Different 
from canonical SH3 domains which have 5 β-strands, SH3 in PSD-95 has 6 β-strands. 
The GK is inserted between the 5th and 6th β-strands, and forms a hydrophobic contact 
with the SH3 domain (Fig. 1.4). The GK domain of PSD-95 has 40% sequence homology 
to yeast guanylate kinase. Structurally, GK in PSD-95 resembles the open form of yeast 
guanylate kinase. However, unlike other guanylate kinases, the GK in PSD-95 has no 
catalytic activity to convert GMP to GDP. Instead, GK evolved into a protein binding 
domain. Currently identified GK binding targets include AKAP79/150[40], MAP1A [28], 
GAKIN[41] and GKAP[42]. The interaction of GK with MAP1A and GKAP was 
thoroughly studied by Reese et al [43]. This study identified key residues for MAP1A 
binding in GK, and suggested that the guanylate binding site of GK served as binding 
groove of MAP1A ([43]). During the binding process, GK domain experiences a 
transition from open to close conformation, while MAP1A assumes an extended 
conformation.  
1.3 Interdomain allostery and regulation of PSD-95 
 
All subdomains of PSD-95 have been studied at a structural level, though only after 
being excised from the reminder of PSD-95. However, emerging observations suggest the 
presence of interdomain communication within PSD-95(and with MAGUK members). 
The first case is the interdomain allostery between PDZ3 and GK of PSD-95. It was 
found that binding of CRIPT to PDZ3 promotes the interaction of GK with its binder, 
MAP1A[28]. This type of domain communication also applies to other PSD-95 
homologues, such as PSD-93, SAP97 and SAP102[28]. Interdomain allostery is also 
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exemplified by the PSD-95 homologue in drosophila, Dlg1, in which PDZ3 is 
indispensible for interaction between SH3 and Gukholder; while, the interaction between 
SH3 and Gukholder is abolished by the presence of PDZ3 binding peptides, such as APC 
and neuroligin[29]. Interdomain allostery is also found between PDZ3 and SH3. Many 
studies have shown that calmodulin binds to the Hook domain of SH3, and interestingly, 
the interaction between the Hook domain and calmodulin is enhanced by the presence of 
PDZ binding peptide, such as CRIPT[38]. As mentioned previously, SH3 and GK are 
structurally interdependent in MAGUK family proteins. Indeed, the interdomain allostery 
between SH3 and GK is evident from mutations at the Hook domain and Hook hinge of 
Dlg1, which constitutively activate the GK domain[44]. 
The allosteric behavior of PSD-95 suggests that PSD-95 is not only a scaffolding 
to concentrate signaling molecules to facilitate complex formation, but also a regulatory 
organizer to ensure the proper binders are targeted at the correct spatial and time order. In 
consideration of the numerous binders targeted and various biological functions involved 
by PSD-95, it is not surprising that PSD-95 is under tight regulation, such as 
palmitoylation and phosphorylation. Palmitoylation is mainly happening at the N-
terminus of PSD-95, while phosphorylation is throughout the primary sequence. Many 
phosphorylation sites have been identified in PSD-95, most of which are located at 
domain boundaries. The function of phosphorylation is poorly documented, and not 
studied at a structural level yet. Phosphorylation of PSD-95 may interplay with 
interdomain allostery to fine tune PSD-95 functions. In the PSD-95 homologue, SAP97, 
phosphorylation of the N-terminal PDZ1 and the linker of PDZ2/PDZ3 by p38γ prevents 
binding of GK to GKAP[45]. The structural and functional coupling of these five 
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domains in PSD-95, and the regulation of PSD-95 by dimerization and phosphorylation 
cannot be fully understood by the “divide and conquer strategy” which has mainly been 
used in structural studies on PSD-95. Since all five domains have solved structures, it is 
an opportune time to assemble them together to understand the interdomain allostery 
within PSD-95.  
Understanding the interdomain allostery within PSD-95 is the main goal of this 
thesis. As a summary, all reported interdomain allostery and phosphorylation sites of 
PSD-95 are tabulated in Table 1.1 and Table 1.2.  
Table 1.1: Interdomain allostery with in PSD-95 family 
MAGUK protein Effecter Domain Effecter Event Responsor Domain 
Responding 
Event 
SAP-97 PDZ3 CRIPT binding Hook Increase binding with calmodulin 
SAP-97 PDZ2/PDZ3 liner Phosphorylation GK 
Disrupt binding 
with GKAP 
PSD-95 PDZ3 CRIPT binding GK Increase binding with MAP1A 
Dlg1 SH3-Hook Mutation GK Increase binding with Gukholder 
Dlg1 PDZ3 CRIPT binding GK Disrupt binding With Gukholder 
 
Table 1.2: Phosphorylation sites in PSD-95 
Residue Location 
T19 N-terminus[46] 
S25 N-terminus[46] 
S73 PDZ1[47] 
S142 PDZ1[32] 
Y240 PDZ2[31, 32, 48] 
T287 PDZ2/PDZ3 linker[49] 
S290 PDZ2/PDZ3 linker[45] 
S295 PDZ2/PDZ3 linker[32] 
Y397 PDZ3[30] 
S415 PDZ3/SH3 linker[48] 
S418 PDZ3/SH3 linker[32, 48] 
Y432 SH3[48] 
Y533 SH3/GK boundary[50] 
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1.4 hPTP1E PDZ2 
 
Protein tyrosine phosphatase BL (PTP BL) is a cytosolic non-receptor type 
phosphatase. This phosphatase is found to be involved in regulation of cell apoptosis, 
cytokinesis, cell surface expression of Fas, and suppression of ephrinB 
phosphorylation[51]. Full length PTP BL has 2490 amino acids. From the N-terminus, 
PTP BL consists of a KIND domain, a FERM domain, five PDZ domains (named as 
PDZ1-5) and a phosphatase catalytic domain. Of the five PDZ domains, the second PDZ 
domain (PDZ2) is thoroughly studied. PDZ2 binds to Class I (APC) and Class III 
peptides (RIL).   
1.5 Overview of this work 
 
The ultimate goal of this work is to understand how interdomain communication 
of PSD-95 is carried out and how phosphorylation regulates PSD-95 function. The 
motivation for this project is actually stem from studying the phosphorylation of PDZ3 as 
described in Chapter 2.  
In Chapter 2, we studied the phosphorylation of PDZ3 at Y397, which is located 
at the third α-helix. Upon phosphorylation of Y397, as shown in our research, the third α-
helix becomes undocked from the main part of PDZ3 and exists as an unfolded coil. We 
further showed that this phosphorylation weakens the domain packing between PDZ3 and 
SH3.  
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These results presented in Chapter 2 hint that interaction between SH3/GK may 
provide the structural basis by which interdomain allostery of PSD-95 can be carried out. 
Therefore in research described in Chapter 3, we made an effort to build a structural 
model of MAGUK core, PDZ3-SH3-GK. To build this model, we employed NMR 
paramagnetic relaxation enhancement (PRE) to provide long distance constraints and 
small angle X-ray scattering (SAXS) to probe the envelope of PDZ3-SH3-GK. The 
MAGUK core structure sheds light on how interdomain communication may be carried 
out. The MAGUK core structural model enables us to obtain full length PSD-95 structure 
with SAXS data. A structural mechanism for interdomain allostery of PDZ3/SH3 and 
PDZ3/GK are proposed, and function of the Hook domain is discussed. 
In Chapter 4, we studied intramolecular allosteric-like behavior of hPTP BL 
PDZ2 using both NMR and crystallography. Our research settles a nagging ambiguity in 
PDZ2 studies: whether PDZ2 experience structural changes upon peptide binding. Our 
research suggested that peptide binding does not incur significant structural perturbation 
on PDZ2, whereas perturbations on fast time scale dynamics are radiated to distal sites 
from the peptide binding groove.    
1.6 NMR relaxation and protein dynamics 
 
Proteins can be thought of as dynamic machinery, which possesses motions on 
time scales from ps to seconds. Dynamics at different time scales is related to different 
motional modes, and to different biological functions (Fig. 1.5). Dynamic information of 
proteins can be studied by several experimental methods, such as fluorescence and 
infrared spectrum[52, 53]. However, atom specific information of a molecule cannot be 
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obtained by these two methods. X-ray crystallography B-factors provide site specific 
dynamic information, but interpretation of B-factors is highly skewed by the crystal 
packing. Besides, B-factors from flexible loop regions are unreliable due to poor electron 
density.  
NMR is the most powerful tool by which to study protein dynamics. NMR 
provides a repertoire to probe dynamics on time scales from ps-s (Fig. 1.5). Two 
timescales relevant to this thesis are ps-ns, and μs-s timescale dynamics, which are briefly 
introduced below.  
NMR relaxation is the process by which nuclear spins return to thermal 
equilibrium state from an excited state created by a pulse or pulses of electromagnetic 
radiation [54]. For the nuclei of bio-molecular interest, such as 13C and 15N, the two most 
important relaxation mechanisms are dipole-dipole interactions and chemical shift 
anisotropy (CSA) [54, 55]. Both relaxation mechanisms are directly related to rotational 
and internal motions of proteins. It is the direct relationship of protein motions to 
relaxation that makes NMR capable of quantifying protein dynamics. 
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Figure 1.5: Timescales of protein dynamics and appropriate NMR methods.  
 
In the presence of an external static magnetic field, NMR active nuclei of a 
molecule can be visualized as small magnetic dipoles. Besides experiencing the external 
field, nuclei also sense the presence of “tiny” local fields created by surrounding nuclei. 
The strength of the external field is constant, but the local fields created by nuclear 
dipoles are orientation dependent. As shown in Fig. 1.6, nucleus A senses a different 
strength and direction of the local field created by nucleus B, depending on the relative 
orientation of A and B. For a protein undergoing rotational and internal motions, the 
relative orientation of a pair of nuclei pairs also changes accordingly. Therefore 
fluctuating local fields are created by protein motions. The fluctuating local field 
facilitates the energy transfer between the nuclei of protein to the surrounding medium 
(spin lattice relaxation, longitudinal relaxation, R1) and the dephasing or loss of 
coherence of spin (spin spin relaxation, transverse relaxation, R2). 
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Figure 1.6: Dipole-dipole interaction and vector orientation. The magnetic moments of nucleus A and B, 
connected by covalent bond (cyan), are visualized as magnetic bars. The orientation of two nuclei affects 
the dipole-dipole interaction.   
 
CSA arises from the variation in shielding from the external field. When a 
chemical bond in a tumbling molecule is changing its orientation relative to the static 
external field (the anisotropy of the chemical shift tensor), the extent to which the 
external field is shielded by the electron cloud varies. This variation in external field 
shielding produces variation in effective magnetic field experienced by nuclei. Therefore, 
similar to dipole-dipole interaction, a relaxation mechanism is formed.  
1.6.1 ps-ns timescale dynamics 
 
The mathematic relationship between protein motions and NMR relaxation is 
connected by the spectral density function, J(ω). The energy levels of an NMR active 
spin are quantized. Only the portion of motions at appropriate frequencies can stimulate 
spin energy transitions. This means that only a proper tumbling rate or frequency 
contributes to NMR relaxation. However, due to the stochastic nature of molecular 
motions, the frequency of protein motion cannot be described by one or several distinct 
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frequencies. A continuous function, the spectral density function J(ω), describes the 
likelihood of a motion at certain frequency. Experimentally, it is not feasible to map the 
whole spectral density function. Only several frequencies related to the nuclear spin 
resonance can be measured. The relationship between experimental R1, R2 and spectral 
density function and the heteronuclear NOE[56] are given by the following equations[55]: 
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in which, “DD” and “CSA” denote dipole-dipole and chemical shift anisotropy relaxation 
mechanisms, as mentioned; exR  is the relaxation mechanism contributed by chemical 
exchange, which will be talked in the next section.γ is the gyromagnetic ratio of 15N and 1H, 
r is the length of N-H bond, σΔ is the breadth of the CSA tensor, 0μ is the permeability of free 
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space, and h is the Planck’s constant. The spectral density function in above equations does not 
distinguish the rotational motion from protein internal motions, which are more relevant to 
protein functions. Lipari and Szabo, proposed a model to separate the protein rotational motions 
from protein internal motions[57, 58]. This model assumes that the internal motion of protein is 
much faster than protein tumbling and there is no correlation between the two. This model 
doesn’t assume any specific geometry for protein internal motions. Therefore it is also known as 
“the model free” formalism. The spectral density function taking protein internal motion into 
consideration is shown as[55]: 
2 2
2 2
2 (1 )( )
5 1 ( ) 1 ( )
m
m
S SJ τ τω ωτ ωτ
⎛ ⎞−= +⎜ ⎟+ +⎝ ⎠
 
1 1 1
m eτ τ τ− − −= +  
in which, mτ is the protein tumbling correlation time and eτ is the internal effective correlation 
time, S2 is the order parameter for NH bond. Parameter eτ describes the timescale of the internal 
motion, and S2 describes the amplitude of the internal motions. The value of S2ranges from 0 to 1, 
indicating completely random internal motion of chemical bonds and completely rigid motions 
with respect to molecular frame. Therefore S2 is closely related to the rigidity or secondary 
structure of a residue. Usually, residues involved in secondary structures possess higher S2, while 
the random coil or terminal residues without packing tend to have low S2. In this sense, backbone 
order parameters are not typically informative, since they are highly correlated with protein 
secondary structures. 
On the contrary, order parameters of methyl bearing side chains (S2axis) of a protein vary 
from site to site. Measurement of methyl dynamics is based on quadrupole relaxation of 
deuterium in CH2D methyl isotopomers [59]. Many studies have shown that S2axis is directly 
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related to protein conformational entropy, and can be used to calculate protein conformation 
entropy [60-62]. Our studies on PDZ2 suggest S2axis is sensitive to ligand binding. The 
perturbation of S2axis resulting from peptide binding is propagated to sites distant from the binding 
groove [2, 3]. These results revealed for the first time the allosteric-like behavior of PDZ domain. 
Using dynamic information from S2axis, our recent study on the third PDZ domain from PSD-95 
shows truncation of the third a-helix greatly prompts protein dynamics, and decreases peptide 
binding affinity by 20 fold[63]. 
1.6.2 CPMG relaxation dispersion 
 
 Most biological processes, such as enzyme catalysis, protein folding, ligand 
binding and allosteric regulation, tend to occur on μs-ms timescale. Studying protein 
dynamics of μs-ms motions is of fundamental importance in understanding mechanisms 
of these biological processes. Fortunately these processes always incur chemical 
environment changes of nuclei. For example, ligand binding perturbs chemical shifts of 
surrounding binding groove; substrate binding and catalysis changes chemical shifts of 
enzyme active sites; conformational changes alters local protein structure and 
consequently environment of nuclei. Generally speaking, a process in which a spin 
experiences two or multiple chemical environments, and consequently two or more 
chemical shifts is referred to as chemical exchange[64]. The definition of exchange rate 
depends on the exchanging system: for a two-state exchanging system, 
1
1
k
k
A B
−
⎯⎯→←⎯⎯  
1 1exk k k−= +  
For biomolecular association, 
21 
 
1
1
k
k
A B A B
−
⎯⎯→+ •←⎯⎯  
1 1[ ]exk k B k−= +   
in which, kex is the chemical exchange rate, and k1, k-1 are forward and reverse rates 
respectively. 
 Chemical exchange has profound effects on the appearance of NMR spectra 
according to the NMR chemical shift timescale (Fig. 1.7). Depending on the relative 
values of the exchange rate (kex) and the chemical shift difference (Δω), the exchange 
process is classified into three regimes: slow exchange (kex << Δω), intermediate (kex 
≈Δω) and fast exchange (kex >>Δω). In the slow exchange scenario, two distinct 
resonances are observed. With increasing of kex, two sets of peaks gradually become 
coalesced and broadened (intermediate exchange), and finally merge into a single sharp 
peak (fast exchange) whose chemical shift is the population weighted average of the two 
exchanging states.  
 
Figure 1.7: Impact of exchange rate on NMR lineshape. 
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 Chemical exchange makes an extra contribution to spin relaxation besides 
intrinsic relaxation R20, making possible the analysis of chemical exchange using NMR. 
The analysis of chemical exchange depends on the so-called CPMG (Carr-Purcell-
Meiboom-Gill) pulse train, which occupies a constant time block T, but contains varying 
numbers of 180⁰ refocus pulses (-τcp-180⁰-τcp-)[65]. The interval between neighboring 
180⁰ pulses is called τcp, which can be varied from several µs to 10 ms. The basic idea for 
how CMPG works is that when an exchanging process is comparable to the length of τcp, 
the relaxation due to chemical exchange cannot be refocused by the CPMG train. The 
effective or experimental relaxation rate R2eff depends on the density of 180⁰ refocus 
pulses. By varying the number/frequency of 180⁰ refocus pulses, the magnitudes of R2eff 
varies, and this dependence is known as relaxation dispersion. Experimentally, R2eff 
measured at specific τcp intervals is calculated using the following equation[66]: 
2
0
1 ln( )eff IR
T I
= −  
where I and I0 are the intensities with and without CPMG pulse train, T is the constant 
time block. By collecting R2eff at different τcp delays, a curve of R2eff versus τcp can be 
obtained.  
The dependence of R2eff on τcp can be fitted by the Carver-Richards equation for 
two-state exchange[67]: 
0 0 1
2 2 2
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in which, R2a and R2b are intrinsic relaxation rates of state A and B, pa and pb are the 
populations of state A and B, satisfying pa+pb=1, and Δω is the chemical shift difference 
between state A and B.  
 Relaxation dispersion contains kinetic and thermodynamic information. In 
combination of exchange rate kex and dissociation constant, forward rate and reverse rate 
constant can be further deduced. State populations (pa and pb) derived from relaxation 
dispersion curves provide the energy relationship of two states. It is noteworthy that 
CPMG relaxation dispersion enables detection of lowly populated state, i.e., excited state 
(<5%). Although relaxation dispersion only provides the magnitude of the chemical shift 
difference of two states, the sign of Δω can be retrieved from HSQC/HMQC 
experiments[68]. With both magnitude and the sign of Δω, the chemical shift of the 
excited state can be obtained. Obtaining this kind of information can yield new insight 
into protein structural state. Using relaxation dispersion, Korzhnev deduced chemical 
shift and residual dipolar couplings of unfolding intermediate states of FF domain, and 
simulated the structure of intermediate state, which is unavailable for other methods[69].    
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1.6.3 Application of PRE to protein structure and dynamics studies 
 
One of goals of this thesis is to build a structure model of MAGUK core, which 
consists of PDZ3, SH3 and GK domain. The molecule weight of MAGUK core is 47 KD. 
The size of the protein makes chemical shift assignments difficult. The chemical shifts of 
isolated PDZ3 was assigned by our lab, but the chemical shift assignments for SH3 and 
GK domain are unavailable. Without chemical shift assignment, it is impossible to 
employ NOE to find interdomain distance constraints. Moreover, our study showed 
MAGUK core is highly dynamic. This domain flexibility also makes obtaining high 
quality data unpractical. Besides, NOE is only suitable for providing short distance 
information, which may be not competent for our inter-domain packing situation. To 
overcome these difficulties, we adapted paramagnetic relaxation enhancement (PRE) to 
obtain long distance constraints. 
Paramagnetism arises from unpaired electrons in an atom[70]. Just as the spinning 
of a positively charged nucleus creates a magnetic moment parallel to its spin direction 
(which is fundamental of NMR), spinning of a negatively charged electron generates a 
magnetic moment anti-parallel to its spin direction. For most elements, the magnetic 
moments of electrons are not detectable, because paired electrons tend to cancel each 
other’s magnetic moments. Due to the configuration of electron orbitals, some elements 
have unpaired electrons, which produce strong local magnetic moments. With an external 
field applied, those local magnetic moments tend to align with the external field. This 
phenomenon is known as paramagnetism.   
Historically, application of PRE was mainly confined to metalloproteins with 
paramagnetic metal ions, such as Cu2+ and Ni2+[71]. Recent developments in the 
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synthesis of nitroxide chemicals make available paramagnetic labeling for protein 
molecules. This extends the application of PRE to studies of protein structure. At present, 
commercially available paramagnetic labeling reagents for proteins mainly consist of 
nitroxide derivatives and EDTA chelator derivatives (Fig. 1.8)[72]. Both types of 
chemicals can be conjugated to cysteine sidechains in proteins by formation of a disulfide 
bond.  
 
Figure 1.8: Paramagnetic labeling chemicals. (A) MTSL (B) EDTA derived paramagnetic chemicals. The 
shaded parts are leaving groups, which are not adducted to proteins or DNA. 
 
 In a paramagnetic system with anisotropic g-tensor, three observations are 
available: pseudo-contact shift (PCS), paramagnetic relaxation enhancement and residual 
dipolar couplings (RDC) (PRE) [73], if the spin labeling center are able to align the 
sample. Although PCS and RDC of a paramagnetic system contain information of 
molecular structure and dynamics, mathematic models to analyze these observations are 
not well developed, and application of PCS and RDC exceeds the scope of this work. We 
will not further discuss PCSs and RDCs of a paramagnetic system.  
 For a paramagnetic system with isotropic electron g-tensor, PRE is the only 
detectable effect. The PRE derives from the dipole-dipole relaxation between unpaired 
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electrons and the nucleus of interest, and increases rate of spin relaxation. The enhanced 
longitudinal relaxation rate Γ1 and transverse relaxation rate Γ2 are related to molecule 
structure and dynamics by the Solomon-Bloembergen equations (SB-equations) [74]: 
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 in which, γ is the gyromagnetic ratio, ω/2π is the Larmor frequency, r is the distance 
from paramagnetic center to the nucleus of interest, τc is the correlation time, τr is the 
protein rotational correlation time and τs is the electron relaxation time. ( )J ω is the 
spectral density function. Note that S here is the spin quantum number for an electron 
(not to be confused with the order parameter). In this equation, r provides the distance 
information which is usually used as a constraint for structure calculation and refinement. 
Compared with NOE distance constraints, which are shorter than 6 Å, PRE can detect 
distance up to 25 Å.  
Besides providing distance information suitable for structure calculation and 
refinement, the PRE provides information on protein dynamics [75, 76]. Particularly, the 
PRE is one of two methods other than relaxation dispersion to probe structural or 
dynamic information of minor population states. It is relatively straightforward to analyze 
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PRE data in the fast exchange on the NMR timescale. Consider a system exchanging 
between state A and B, in which the state A is highly populated, and far from 
paramagnetic labeling group, while the sate B is of low population and near to labeling 
group. When the exchange rate kex between the two states is fast enough, i.e. 
2, 2,ex B Ak >> Γ −Γ , the experimentally observed PRE, Γ2app can be approximated by 
following equation[75]: 
2 2, 2,
app
A A B Bp pΓ ≈ Γ + Γ , 
where ap and bp  are the percentage populations of states A and B, and  2, AΓ  and  2,BΓ are the 
theoretical transverse PREs calculated based on structures of state A and B. Though state B is 
lowly populated, its vicinity to the labeling group produces strong PRE due to the 6r−  
dependence of the PRE on distance, making information from state B still detectable.  
 When applying the method, several cautions should be kept in mind. First, as 
shown by the SB equation, the magnitude of the PRE is proportional to the square of the 
gyromagnetic ratio. This means in biological molecules, protons are most sensitive to the 
PRE, while nuclei such as 15N and 13C are not sensitive enough to give accurate PRE 
values. From our experimental data, the 1H-PRE,  Γ2, ranges from 3 to 70 s-1; while the 
largest magnitude of 15N is around 4 s-1. Second, Γ2 is more often used in structure 
calculation or refinement, because Γ2 is less susceptible to the internal motion of 
molecules[77]. Third, due to flexibility of the paramagnetic labeling group, accurate 
positioning of the paramagnetic center cannot be represented by a single conformation of 
paramagnetic group[77]. In practice, conformational ensembles of labeling groups are 
used in calculation of distances between the paramagnetic center and the nucleus of 
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interest. Also, paramagnetic samples should be freshly prepared to minimize diamagnetic 
contaminants, which can result from breaking of the disulfide bond[78]. 
1.6.4 Small Angle X-ray Scattering 
 
  Recent years have witnessed a surge in application of small angle X-ray 
scattering (SAXS) to bio-molecules. Compared with other biophysical methods, SAXS is 
superior to NMR for proteins with high molecular weight, to crystallography for proteins 
that are too flexible to obtain crystals, or proteins whose function can only be understood 
in the context of structural ensemble.  
 The physical principles and experimental setup of SAXS is the same as those for 
X-ray crystallography. A 1D scattering curve is obtained between scattering intensity and 
scatter angle. The different scattering appearance between SAXS and X-ray diffraction 
derives from the internal order of sample [79]. Unlike crystallography, which is acquired 
in the crystalline state, SAXS data are collected in the solution state in which molecules 
rotate and diffuse freely. Structural information given by SAXS therefore is time and 
orientation averaged. For mathematical simplification, the SAXS scattering curved is 
usually described by scattering intensity, I  and momentum transfer, q : 
4 sinq π θλ=  
where 2θ is the diffraction angle and λ is the wavelength of incident X-ray beam. The scattering 
intensity ( )I q  is related to molecule structure by the following equation [80]: 
2
( ) ( ( ) ) iq rsI q r e drρ ρ •= −∫ v vv v  
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in which  represents the rotational average; ( ) srρ ρ−
v
is the scattering density difference 
between particles and solvent, and will be shown as ρΔ thereafter.  
 Though scattering intensity is correlated with molecular shape, it does not provide 
structural information in a straightforward way. A more intuitive way to extract particle structure 
information is given by the pair distribution function ( )P r , which can be obtained by reverse 
Fourier transformation of following equation[79]: 
max
0
sin( )( ) 4 ( )
D qrI q P r dr
qr
π= ∫ , 
 where maxD  is the maximum distance that can be found in a molecule. The pair distribution 
( )P r  is a counterpart of the Patterson function in crystallography. The pair distribution function 
basically describes the frequency at which a distance pair can be found in a molecule. The pair 
distribution function can also be obtained from a protein structure, as[79]: 
2( ) ( ) ( )
V
P r r r u r duρ ρ= Δ Δ +∫ , 
where the integral is carried out over all volume of the molecule. The PDF contains structural 
information such as radius of gyration, maximum diameter and molecular shape. The PDFs of 
different molecular shapes have been well exemplified by Svergun[81]. Although for a certain 
molecular structure, a unique PDF is defined, the reverse is not true. For a given PDF, different 
structural models can be deduced. For example, PDF cannot distinguish enantiomers.  
 Usually there are two ways to build a structural model using SAXS. The first is an ab-
initio method [82, 83]. For ab-initio method, the protein chain is simplified as a thread of 
spherical beads. The string of beads is folded at random to form a compact sphere. The SAXS 
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curve of the model is calculated and evaluated by comparing with experimental SAXS data. The 
other way is to build a structural model using rigid body modeling [84, 85], which is particularly 
powerful for solving structures of multi-domain proteins given individual domain 
structures. Compared with ab-initio methods, rigid body docking overcomes the problem 
of over-parameterization. Usually models built in this way are more converged. However, 
due to the dynamic nature of some multiple proteins, a single conformation is not 
sufficient to yield acceptable fitting of experimental SAXS data. The problem is solved 
by the ensemble optimization method (EOM) [86]. In this method, a pool of 
conformations (> 10,000 structures) is first generated, and then the best combination of 
conformations is selected by a genetic algorithm[86].  
 To obtain usable scattering data, several requirements on protein samples should 
be met and procedural cautions should be taken. First, SAXS requires sample 
monodispersity. The most deleterious and often encountered problem is protein 
aggregation or oligomerization. A seriously aggregated sample can be immediately 
distinguished by the so-called Guinier plot, i.e. log I  and 2q . A monodispersed sample 
yields a linear region up to gR q <1.3, while an aggregated sample shows a curved region 
that is tilted up at low q[80]. However, even the Guinier plot is unable to sense subtle 
aggregation. To probe subtle aggregation, SAXS data at different concentrations are 
required. For an ideal sample, gR calculated from different sample concentrations is 
constant, while slightly aggregated or oligomerized sample have increased gR with 
increasing concentration[79]. Therefore, it is routine to prepare SAXS samples of 
concentrations ranging from 0.5 to 5 mg/ml. Second, SAXS is in essence a contrast 
method. This requires that the background scattering from solvent has to be subtracted 
31 
 
precisely. To this end, samples must be prepared using either size exclusion 
chromatography or lengthy dialysis. At the same time, size exclusion column 
equilibration buffer and dialysate should be used for determining the background 
scattering which needs to be subtracted off. Third, high intensity of X-ray generates large 
amount of radicals and could result in radiation damage of protein sample. The radiation 
damage degrades protein samples or incurs protein aggregation. The radiation damage 
can be detected by the gradual change in scattering curves. Scavengers, such as DTT or 
ascorbic acid are useful to reduce radiation damage[87].  
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Chapter 2 
Phosphorylation of a PDZ domain extension 
modulates binding affinity and interdomain 
interactions in the PSD-95 MAGUK 
2.1 Introduction 
 
Phosphorylation is the most common covalent modification made to proteins in 
eukaryotes. Depending on the protein substrate, it can regulate the gain or loss of activity 
through a variety of mechanisms. Most mechanisms studied to date appear to work via a 
change in steric geometry at the active site or a global conformational change in the 
protein [88-90], although a few recent examples indicate modulation of protein dynamics 
that can yield a graded response [91, 92]. Overall, the extent of structural characterization 
of phosphorylation mechanisms is scarce given the ubiquity of this post-translational 
signaling mechanism and the large diversity of effects observed upon phosphorylation. A 
greater understanding of how phosphorylation(s) modulate protein activity is essential to 
understand signal transduction processes such that they may be manipulated for desired 
effect.  
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Figure 2.1: Domain architecture of PSD-95. The five domains of PSD-95 are shown, and sequences of α3 
region and PDZ3/SH3 linker in MAGUK family from different organisms are aligned. The conserved 
tyrosine (Y397) and two serine phosphorylation sites (S415 and S418) are denoted by “*”. The alignment 
was done using ClustalX 2.0.12. 
 
Many phosphorylated proteins are multi-domain, modular proteins [89-91]. 
MAGUK (membrane-associated guanylate kinase) family proteins are multi-domain 
scaffolding proteins that play roles in signal transduction and cellular adhesion at cell-cell 
junctions [93]. The defining MAGUK signature is the PDZ-SH3-guanylate kinase 
“supradomain” architecture. The best known MAGUK protein is postsynaptic density-95 
(PSD-95), which is found on the cytoplasmic side of post-synaptic terminals. PSD-95 is a 
non-catalytic scaffolding protein that assembles macromolecular complexes for signal 
integration at excitatory neurons. It consists of three PDZ (PSD-95/Discs large/Zo-1) 
domains, an SH3 domain, and a non-catalytic guanylate kinase (GK) domain (Figure 2.1). 
PDZ domains are ~90 residues, globular, protein interaction domains that have a 
conserved fold comprised of two α-helices and five β-strands. The function of PDZs is 
typically to bind the C-terminal 4-5 residues of target proteins, which bind in a groove 
between α2 and β2 of the PDZ. PDZ domains are often found in tandem copies and are 
common to proteins that function as scaffolds for assembling signaling complexes or 
trafficking components at cell-cell junctions. In PSD-95, its PDZ domains bind many 
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proteins ranging from NMDA and adrenergic receptors to neuronal nitric oxide synthase 
(nNOS), Pyk2, SynGAP, and microtubule assemblies [6]. Structural work has been 
carried out on individual PDZs of PSD-95 [9, 94], as well as the SH3-GK module [35, 
36]. However, little is known about how MAGUK PDZ domains associate/function with 
the SH3-GK module. A role for PDZs beyond their normal C-terminal ligand binding 
function has emerged from examples in which intermolecular (or interdomain) contacts 
occur on novel PDZ interfaces [14, 95] or binding is regulated allosterically [14, 63, 96-
98].  
Previous work suggests that the third PDZ domain (PDZ3) in PSD-95 family 
proteins regulates activity at SH3-GK, indicating that this PDZ domain may have 
additional regulatory function on top of its C-terminal binding function. MAP1A binds to 
the GK domain of PSD-95; however, this interaction is weakened by the presence of 
PDZ3 (and abolished by the presence of all three PDZ domains) and restored by PDZ 
binding peptides such as APC, NR2B and CRIPT [28]. Interdomain interactions were 
also characterized in the drosophila homologue of PSD-95, Dlg-1, in which the domain 
interaction between PDZ3 and SH3 was regulated by PDZ3 binding peptide [29]. The 
region linking PDZ3 and SH3 is vital to the interdomain communication between these 
two domains. Replacement of the conserved linker region with flexible Gly-Ser repeats 
disrupts the influence that PDZ3 has on binding of SH3 to its interaction partner, 
GukHolder [29]. Thus, a major question regarding MAGUKs is what is the role of the 
PDZ domain preceding SH3-GK and how might it participate in intramolecular, 
interdomain interactions?  
35 
 
Interestingly, PSD-95 is known to be phosphorylated at up to a ~dozen sites, with 
several of these sites being at linker positions in-between structured domains as well as 
one in a C-terminal helical extension to PDZ3 (Figure 2.1). To date, phosphorylation has 
received modest attention as a means of regulating PDZ domain function in general. One 
exception is the PDZ protein NHERF1, for which phosphorylation has been shown to 
regulate PDZ-mediated autoinhibition[99]. Although studies of phosphorylated PDZ 
domains are rare, there are numerous instances of phosphorylation of PDZ C-terminal 
ligands which can either decrease [100-105] or increase [106-108] affinity to their 
cognate PDZs. Recently, we showed that folding of a C-terminal extension to PDZ3 into 
an α-helix (α3) increases binding affinity to PDZ3 ligand via an allosteric mechanism 
rooted in changes in picoseconds-nanosecond side-chain dynamics [63]. The α3 helix is 
not part of the conserved PDZ fold and hence appeared as an unusual auxiliary element 
whose function had been unclear. Within the α3 helix,Y397 can be phosphorylated [30], 
which in principle could either increase or decrease α3 interactions with the PDZ core. In 
addition to Y397, the nearby residues S415 and S418 can also be phosphorylated [31, 32]. 
This dense collection of phosphorylation sites suggests that this region (C-terminal 
extension of PDZ3 and the PDZ3-SH3 linker) is a hot spot for MAGUK regulation. 
Interestingly, structured “extensions” to PDZ domains are now being discovered in more 
PDZ domains [109]. 
To probe the role of the third PDZ domain (PDZ3) in the PSD-95 MAGUK and its 
transition into the linker leading into the SH3 domain, we have chosen to study by NMR 
the effect of phosphorylation at three sites in the C-terminal region of PDZ3 and how 
such phosphorylations modulate PDZ3 structure, function, and its interaction with SH3-
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GK. A construct of PDZ3 spanning residues 304-402 was phosphorylated at Y397 (p397-
PDZ3) and characterized for structural effects. A combination of chemical shift analysis, 
hydrogen exchange, 15N relaxation, and isothermal titration calorimetry showed that 
phosphorylation induces a fast equilibrium between a docked conformation in which α3 
is packed against the PDZ core and an undocked, flexible state of α3 which has reduced 
affinity for PDZ3 ligands. We also show that the effect of α3 is not specific to the classic 
PDZ3 C-terminal ligand from CRIPT, as it influences binding to other C-terminal ligands. 
In a second construct of PSD-95 spanning PDZ3-linker-SH3, phosphorylation at all three 
sites (397, 415 and 418) was shown to increase mobility of PDZ3 relative to SH3. These 
studies provide insight into how phosphorylation affects structure and dynamics of an 
intrinsically flexible, multidomain system. They also show for the first time that PDZ3’s 
association with the SH3 domain in PSD-95 is weakened by multiple phosphorylations.  
2.2 Experimental Procedures 
2.2.1 Protein expression and purification 
 
The third PDZ domain (PDZ3, 304-402) and PDZ3-SH3 tandem (304-532) from rat 
PSD-95 were sub-cloned into pET21a vector with a TEV cleavable N-terminal histidine 
tag. The PDZ3-SH3 tandem was stabilized by adding the sequence SGSGSGPYIWVP-
AREERL to its C-terminus, where bold residues are from residues 713-724, which form 
the F-strand of theSH3 domain. PDZ3-SH3 single mutant (PDZ3-SH3 Y397E) and triple 
mutant (Y397E/S415E/S418E) were made by multiple-site mutagenesis PCR [110]. 
Transformed E. coli BL21 (DE3) cells were grown at 37 °C in LB medium or minimal 
medium containing appropriate isotopes. When cell density reached an OD600 of 0.6, 
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IPTG was added to a final concentration of 1 mM and the cells were grown for another 
16 hours at 22 °C. The cells were harvested by centrifugation and stored at -80 °C until 
use. 
To purify PDZ3, the cell pellet was re-suspended in 50 mM Tris-HCl, pH 8.0, 200 
mM NaCl, 0.1% triton X-100, 25 mM imidazole and 1 mM lysozyme. The re-suspended 
cells were frozen and thawed for three cycles and applied to sonication. The centrifuged 
cell lysate was loaded to a nickel affinity column and eluted with 500 mM imidazole. The 
fractions containing PDZ3 were pooled and subjected to overnight TEV cleavage at 4 °C. 
A 100% cleavage was achieved as suggested by SDS-PAGE. Cleaved samples were 
further purified by Source Q ion exchange chromatography, followed by a G50 size 
exclusion column equilibrated in a buffer containing 22 mM NaPO4, pH 6.8, 55 mM 
NaCl and 1.1 mM EDTA. p397-PDZ3 was separated from PDZ3 using a source-Q resin 
with a 260 ml linear gradient from 0-500 mM NaCl in 20 mM Tris-HCl pH 7.0 (Figure 
2.2A). The identity and purity of the protein were verified by mass spectrometry and 
SDS-PAGE. The protein concentration is determined by UV with an extinction 
coefficient of ε280=2980 cm-1M-1. Phosphorylation changes the UV absorbance profile of 
tyrosine with an extinction coefficient of 593 cm-1M-1 at 268 nm [111]. Taking the other 
unphosphorylated tyrosine (Y392, ε268=1114 cm-1M-1) into account, the concentration of 
p397-PDZ3 was determined using an extinction coefficient of 1707 cm-1M-1 at 268 nm. 
PDZ3-SH3 single and triple mutants were purified using the aforementioned 
protocol with modification at the size exclusion chromatography step, where elution 
buffer contained 50 mM Tris-HCl, pH 7.5, 200 mM NaCl and 1 mM DTT. 
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The plasmid encoding c-Src kinase was a gift from John Kuriyan (UC Berkeley) 
and Sharon Campbell (University of North Carolina at Chapel Hill). The c-Src kinase 
domain was purified as described [112]. 
2.2.2 Peptide synthesis 
 
A 7-mer CRIPT peptide (Ac-NYKQTSV-COOH) was synthesized and purified as 
reported [63]. The identity and purity of the peptide were verified by mass spectrometry. 
The peptide concentration is determined using UV with an extinction coefficient of 1490 
cm-1M-1.  
2.2.3 Isothermal Titration Calorimetry experiments 
 
ITC experiments were carried out on a MicroCal VP-ITC microcalorimeter and 
repeated twice to estimate error. PDZ3 and p397-PDZ3 ITC measurements were 
performed by titrating 1 mM CRIPT peptide into 0.1 mM protein. In total, 280 μl of 
CRIPT peptide was titrated into 1.4 ml protein solution by 40 steps with a 3-minute 
interval between injections. The dilution effect was estimated by performing the same 
titration procedure without protein. Both peptide and proteins were dissolved in the same 
buffer containing 20 mM NaPO4, pH 6.8, 50 mM NaCl and 1 mM EDTA. Data were 
integrated and analyzed using Origin version 5.0 (MicroCal). Kd, ΔH, ΔS and N were 
fitted with a single binding site model. For PDZ3-CRIPT and p397-PDZ3-CRIPT titrations, 
c-values were 27.8 and 7.2 respectively.  
2.2.4 NMR assignments and relaxation experiments 
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PDZ3 and p397-PDZ3 NMR samples were dissolved in 20 mM NaPO4, pH 6.8, 50 
mM NaCl, 1 mM EDTA and 10% D2O at a protein concentration of 1 mM. NMR spectra 
were acquired on a 500 MHz magnet equipped with a 1H/15N/13C probe and z-axis pulsed 
field gradients. Backbone resonance assignments for p397-PDZ3 were obtained using 3D 
HNCACB and CBCA(CO)NH experiments [113]. Backbone relaxation experiments were 
carried out as described on a 500 MHz magnet[63]. T2 relaxation data of wild-type 
PDZ3-SH3, Y397E PDZ3-SH3 and Y397E/S415E/S418E PDZ3-SH3 mutants were 
acquired on a 500 MHz magnet with cryoprobe at a protein concentration of 0.5 mM. 
Wild-type and mutant PDZ3-SH3 constructs were dissolved in a buffer containing 50 
mM Tris-HCl, pH 7.5, 200 mM NaCl, 10% D2O and 1 mM DTT. All NMR spectra were 
processed by NMRPipe and analyzed by NMRViewJ.  
2.2.5 SEA-HSQC experiments 
 
Solvent exposed amide-HSQC spectra were collected on a 500 MHz magnet 
equipped with a 1H/15N/13C probe and z-axis pulsed field gradients at 298 K. The original 
SEA-HSQC pulse sequence was developed by Lin et al. using CLEANEX-PM mixing 
scheme. In this study, a Biopack version of SEA-HSQC pulse sequence was used. The 
inter-transient delay was to 1.5 seconds, and mixing time 0.1 second. The spectra of 
PDZ3 and p397-PDZ3 were collected at protein concentration of 1 mM with 16 transients. 
NMR intensity is a function of several factors such as protein concentration, nuclear 
relaxation time, solution conductivity and protein tumbling time. Of these factors, protein 
tumbling time is significantly influenced by phosphorylation (see Results). This 
necessitates a method to scale the SEA-HSQC intensities of PDZ3 and p397-PDZ3 to 
allow direct comparison. The scaling procedure used the residues that are not affected by 
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phosphorylation, i.e., those residues that experience slight or nearly no chemical shift 
perturbation as shown in Fig. 2.3A. The SEA-HSQC peak intensities of p397-PDZ3 for 
these residues were scaled to match those of PDZ3.  
2.3 Results 
2.3.1 Phosphorylation of Y397 and purification of phosphorylated PDZ3 
 
From the crystal structure of PDZ3 [9], the side chain of Y397 is partially buried 
between α3 and the core domain of PDZ3. This tyrosine residue is phosphorylated in 
mouse brain, although it is unknown which kinase in vivo is responsible for its 
phosphorylation. Using the Group-based Prediction System [114], Src kinase was 
predicted to be capable of phosphorylating Y397. After treatment of 15N-labeled PDZ3 
with c-Src, a new set of resonances were observed in the NMR HSQC spectrum of PDZ3. 
The relative peak intensities suggested that only 10% of PDZ3 was phosphorylated. The 
reaction went to further completion after removing ADP by dialysis and adding fresh 
ATP, which was repeated four times. This yielded ~40% p397-PDZ3. Mass spectroscopy 
further confirmed a single phosphorylation of PDZ3 at Y397.  
Ion exchange chromatography was used to purify p397-PDZ3 based on the additional 
negative charge introduced by phosphorylation. The elution profile displayed five 
discrete species, three of which tested positive for protein (Figure 2.2A). The first peak 
was confirmed to be PDZ3 from HSQC, and the third peak as pure phosphoPDZ3. An 
overlay of HSQC spectra of PDZ3 and putative p397-PDZ3 shows peaks shifting in 
regions of PDZ3 consistent with modification at Y397 (Figure 2.2B). The identity and 
purity of the third peak was also confirmed to be phosphorylated PDZ3 at Y397 by mass 
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spectrometry. We note that the PDZ3 construct used has only one other tyrosine at 
position 392, thereby increasing the probability that singly phosphorylated PDZ3 can be 
obtained. The above procedure was used to obtain milligram quantities of p397-PDZ3 for 
further biophysical characterization. 
 
Figure 2.2: Purification of phosphoPDZ3. (A) Ion exchange chromatography elution profile of 
phosphoPDZ3 purification, monitored by UV absorbance at 280 nm. The NaCl elution gradient is shown as 
straight lines. (B) 15N-HSQCs of phosphoPDZ3 (red) and wild type PDZ3 (black). 
 
2.3.2 Phosphorylation-induced undocking of α3 lowers affinity for 
CRIPT ligand 
 
To determine the effect of phosphorylation at Y397 on PDZ3 structure, the 
backbone chemical shifts of p397-PDZ3 were assigned and compared to unphosphorylated 
PDZ3. Chemical shift perturbations (CSP) were quantified by measuring the difference 
between the chemical shifts of PDZ3 and p397-PDZ3 (Figure 2.3A), and these CSPs were 
mapped onto the structure of PDZ3 (Figure 2.3B). Phosphorylation results in CSPs 
radiating out from Y397 to include all of α3 and its surrounding regions. While the 
perturbation pattern is consistent with the general site of phosphorylation, the extent and 
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specific nature of any structural change accompanying phosphorylation is more difficult 
to assess strictly from CSPs.  
 
Figure 2.3: Chemical shift perturbation of Y397 phosphorylation. The 15N-HSQC of PDZ3 and 
phosphoPDZ3 are compared and average chemical shift changes of 1H and 15N were plot versus residue 
number (A) and onto crystal structure of PDZ3 (B) using color scale. The average chemical shift 
perturbations were calculated as |Δδ1H|+0.1*|Δ δ 15N|. The Y397 is shown by sticks and the residues 
without perturbation data are color in green. 
  
In unphosphorylated PDZ3, the side chain of Y397 packs into side chains of β2, β3 
and the α1-β4 loop of the PDZ core. These hydrophobic interactions help to define how 
α3 packs against the PDZ core (Figure 2.3B). One possible consequence of 
phosphorylation is therefore destabilization/unfolding of α3, since the phosphate group 
might occlude proper packing of α3. In this sense, phosphorylation of Y397 would 
effectively convert PDZ3 into a C-terminally truncated form, much like PDZ303-395 
characterized previously and referred to as Δ7ct [63]. To test this idea, we compared 1H 
and 15N amide chemical shifts of PDZ3, p397-PDZ3 and Δ7ct by superimposing HSQCs 
of the three proteins. Nearly all residues experiencing significant CSPs in p397-PDZ3 
(Figure 2.3) display a linear trend of HSQC peaks in the order PDZ3, p397-PDZ3, and 
Δ7ct (Figure 2.4A). To quantitatively demonstrate linearity of these three sets of 
resonances, correlation values (adjusted R-values) of linear fitting were calculated and  
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Figure 2.4: Linear resonance pattern of PDZ3, phosphoPDZ3 and Δ7ct 15N-HSQCs. (A) Four representative 
residues were selected to show the HSQC resonance pattern of PDZ3, phosphoPDZ3 and Δ7ct. HSQC 
peaks of PhosphoPDZ3 (green) fall onto the line defined by PDZ3 (blue) and Δ7ct (red) resonances. 
Adjusted correlation value (R-value) for each example residue is given in each panel. (B) Adjusted 
correlation values (R-values) of the resonances with significant chemical shift changes upon 
phosphorylation. Only the residues with CSP>0.05 ppm were analyzed and R-values were showed.  
 
plotted (Figure 2.4B). Most R-values are around 1, suggesting high linearity. Several 
outliers are found for residues near the phosphoryl group on Y397, as expected since 
chemical shifts arise from both conformational and chemical perturbations. The 
collective collinear pattern of PDZ3, p397-PDZ3 and Δ7ct peaks indicates fast exchange 
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between two conformations for p397-PDZ3: one in which α3 is packed as in native PDZ3, 
and one in which α3 is undocked, and makes no contributions to chemical shifts in PDZ 
core residues. Thus, p397-PDZ3 exists as an equilibrium of two dynamically exchanging 
states, represented by PDZ3 and Δ7ct, respectively. The fraction of undocked α3 is ~50% 
and the exchange takes place on a sub-millisecond timescale.  
It was show previously that truncation of α3 decreases binding affinity of PDZ3 
with CRIPT peptide by 21-fold [63]. If p397-PDZ3 is indeed a mixture of PDZ3- and 
Δ7ct-like states, an intermediate binding affinity to CRIPT peptide should be observed. 
To test this, we performed ITC experiments to measure the binding affinity of p397-PDZ3 
to CRIPT C-terminal peptide. The binding affinity of p397-PDZ3 was found to be 
approximately 4 times weaker than PDZ3, falling in between PDZ3 and Δ7ct (Table 1). 
Importantly, this change in ΔG due to phosphorylation is mainly attributed to entropy, 
which is the same signature observed for Δ7ct [63].  
Table 2.1: ITC binding parameters for PDZ3 and phosphoPDZ3. CRIPT peptide 
(NYKQTSV) were titrated in and each experiment was repeated twice. The Kd between Δ7ct 
and CRIPT is 81 µM 
Binding Parameters PDZ3 phosphoPDZ3 
Stoichiometry 0.98±0.03 0.99±0.02 
Kd (µM) 3.60±0.28 14.00±0.47 
ΔH (Kcal/mol) -8.57±0.31 -8.80±0.29 
-TΔS (Kcal/mol) -1.16±0.26 -2.18±0.31 
 
2.3.3 Phosphorylation of Y397 increases disorder in α3 
 
Phosphorylation of Y397 disrupts the packing of α3 with the core domain of PDZ3 
as described above. It is, however, unknown how phosphorylation affects local structure 
of α3. Does α3 still maintain its secondary structure when α3 is undocked from PDZ3? 
45 
 
To answer this question, we analyzed 13C chemical shifts, amide exchange rates, and 15N 
backbone relaxation in phosphorylated and unphosphorylated PDZ3.   
 
Figure 2.5: Cα chemical shift differences of PDZ3 and phosphoPDZ3 relative to random coil. The Cα 
chemical shift differences were calculated by subtraction of random coil Cα chemical shifts from those of 
PDZ3 or phosphoPDZ3. Only β5 and α3 were shown in this plot for clarity. The random coil chemical 
shifts were used as reported by Wishart and Sykes [115].  
 
The 13Cα chemical shift, relative to random coil values, is a sensitive indicator of 
secondary structure [115]. These relative chemical shift values for unphosphorylated 
PDZ3 and p397-PDZ3 are shown for the C-terminal residues that include β6385-392 and 
α3394-398 (Figure 2.5). Phosphorylation clearly diminishes helicity in α3 as determined 
from 13Cα chemical shift, whereas it has no affect on β6 structure.  
Amide proton exchange was characterized by SEA-HSQC (solvent exposed amides 
HSQC) experiments. This approach was used knowing that amides in the α3 region 
exchange rapidly (data not shown). In a SEA-HSQC spectrum, the intensity of an amide 
resonance is proportional to the extent to which it is solvent exposed [116]. As shown in 
Fig. S2.1A, only surface exposed residues of PDZ3 are observed. The undocking of α3 is 
expected to increase solvent exposure, which should be evident from SEA-HSQC 
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intensity changes. It is, however, not appropriate to directly compare SEA-HSQC 
intensities of PDZ3 and phosphoPDZ3 samples, as intensities are differentially affected 
by protein concentration and tumbling times. Therefore, intensities were normalized (see 
Experimental Procedures) to facilitate direct comparison. SEA-HSQC peak intensities of 
PDZ3 and p397-PDZ3 are plotted against one another in Fig. S2.1B. A good correlation is 
obtained as indicated by R-value of 0.98, and a scaling factor of 0.74 (for p397-PDZ3 
relative to PDZ) was observed, indicating increased amide exchange in p397-PDZ3. As 
expected, α3 and its docking region display increased solvent exchange (Figure S2.1C, 
D), while other regions have no significant changes in solvent accessibility. 
 
Figure 2.6: Backbone amide order parameters (S2). The ΔS2 was calculated by subtraction of phosphoPDZ3 
order parameter from PDZ3 order parameter. The residues with significant order parameter changes 
(ΔS2>2σ) are shown by filled bars. The data were acquired on a 500 Varian magnet.  
 
To directly determine the degree of flexibility in p397-PDZ3, we employed 15N 
backbone relaxation coupled with model-free analysis [117] to yield an order parameter, 
S2, for each residue. The most significant change in S2 upon phosphorylation is in the α3 
region, showing decreases of 0.1-0.3 (Figure 2.6). Given that the undocked fraction is 
only 50% and assuming that the docked state yields high values of S2, this represents a 
dramatic increase in ps-ns flexibility in α3, and strongly suggests that in the undocked 
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state it is unfolded and highly dynamic. In addition, a slight overall decrease in S2 is 
observed throughout the PDZ core, which is suggestive of an overall small increase in 
backbone dynamics in p397-PDZ3. These results are similar to that found in Δ7ct, which 
showed large increases in side-chain dynamics and subtle increases in backbone 
dynamics [63]. It is noteworthy that the protein tumbling is greatly retarded by the 
unfolding of α3, as indicated by the increased global tumbling correlation time, τm, which 
increases from 5.9 to 6.7 ns upon phosphorylation at Y397.   
2.3.4 Phosphorylation disrupts PDZ3-SH3 association 
 
In vivo, phosphorylation does not occur in the specific PDZ construct used here 
(304–402), but rather, it occurs in the context of full-length PSD-95 (Figure 2.1). While it 
may not be feasible to probe this 73 kD protein for phosphorylation effects by NMR, we 
hypothesized that some full-length behavior might be captured in shorter multidomain 
constructs. Thus, we set out to characterize the behavior of PDZ3 in a construct that 
spans residues 304-532, which includes the SH3 domain and the linker preceding it. In 
addition, the F-strand from the GK domain (residue numbers 713-724) was added to the 
C-terminus to enhance stability [35]. This PDZ3-SH3 construct yielded reasonable 
quality HSQC spectra from which the effects of phosphorylation could be monitored.    
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Figure 2.7: T2 analysis of PD3-SH3, Y397E and Y397E/S415E/S418E mutants. (A) T2 difference between 
PDZ3-SH3 Y397E single mutant and wild type PDZ3-SH3. (B) T2 difference between PDZ3-SH3 
Y397E/S415E/S418E triple mutant and wild type PDZ3-SH3. (C) The average T2 values for wild type, 
single and triple mutants. The residues with significant T2 increases were shown by filled bars. 
 
In PDZ3 alone, phosphorylation at Y397 increases α3 undocking and unfolding. In 
the intact MAGUK, because α3 precedes a ~20 residue linker, much of which is highly 
conserved, one possibility is that phosphorylation will weaken or enhance putative 
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domain packing between PDZ3 and SH3. To test this, 15N backbone transverse relaxation 
times (T2) were measured in PDZ3-SH3. These T2 times are highly sensitive to the rate of 
tumbling experienced by individual sites. An overall increase in T2 is expected for a 
reduced degree of domain-domain packing since loss of packing would lead to more time 
spent tumbling as a dissociated domain. For these experiments, phosphorylation at 397 in 
PDZ3-SH3 was mimicked by the Y397E mutation. T2 values for this and wild-type 
constructs were measured and their differences are shown in Figure 2.7A. In general, 
PDZ3-SH3 Y397E shows 3~25 ms longer T2 values relative to wild type. It is noteworthy 
that phospho-tyrosine is not perfectly mimicked by glutamic acid. Thus, it is reasonable 
to expect an even larger increase in T2 for authentic phosphorylation of Y397. The 
increase in T2 at virtually all residues suggests that phosphorylation at Y397 reduces the 
interaction between PDZ3 and SH3, which is stabilized by the presence of α3 secondary 
structure. 
Two additional serine phosphorylation sites (S415 and S418) within the PDZ3-SH3 
linker region have been reported [48]. The fragment where S415 and S418 are located 
corresponds to a fragment which was shown to contribute to communication between 
PDZ3 and GK in the PSD-95 homolog Dlg-1 [29]. Specifically, deletion of or 
replacement of this “Δ2” fragment with random coil abolishes SH3’s PDZ3-depdendent 
interaction with GukHolder. Because of these residues’ proximity to α3 and their 
conserved nature (Figure 2.1B), we created a triple “phosphorylation” mutant to test the 
effect of phosphorylation at these two additional sites. 15N T2 measurements were made 
on Y397E/S415E/S418 triple mutant of PDZ3-SH3. Compared with the Y397E single 
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mutant, the triple mutant exhibits even higher T2 values (Figure 2.7B), suggesting further 
dissociation of PDZ3 and SH3 domains.  
2.4 Discussion 
2.4.1 Regulation in PDZ domains 
 
When PDZ domains are excised from their parent proteins, they typically behave as 
simple binders of C-termini, which is documented by the many determined structures of 
individual PDZs and their cognate ligands [118]. Current evidence indicates, however, 
that PDZ function can be influenced by flanking sequences and/or domains, as well as 
intermolecular interactions [109]. The PDZ domain of Par6 alters its binding affinity for 
ligand upon binding of Cdc42 to the semi-Crib motif, which is immediately N-terminal to 
the PDZ domain, and augments its β-sheet [14]. In another example, “PDZ proteases” are 
in turn regulated by changes in PDZ structure [96]. PDZ function has also been shown to 
be regulated by redox events within the PDZ domain [119]. The idea that PDZ domains 
are involved in higher-order regulatory events is consistent with their locations (often in 
tandem) in proteins involved in organization of signaling complexes, sub-cellular 
transport, and cell-cell adhesion [16, 118]. 
Here, we show how PDZ3 from PSD-95 is regulated by phosphorylation of Y397, 
which lies outside the strict PDZ boundary in a C-terminal extension that augments the 
PDZ core structure [9, 63]. Although phosphorylation was shown to regulate function of 
the PDZ protein NHERF1, the phosphorylation sites are far from the PDZ domains and 
their precise mechanism of release of autoinhibition remains to be elucidated [99]. In 
contrast to phosphorylation of PDZ domains themselves, there are numerous examples of 
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phosphorylation of PDZ substrates [100-108]. Phosphorylation typically occurs at 
positions (-2) to (-4), and though this usually results in weakening of the PDZ-ligand 
interaction, there are examples of phosphorylation strengthening the interaction [106-
108]. Thus, phosphorylation appears to be a recurring regulatory mechanism in PDZ 
mediated interactions. Though there is currently little direct characterization of how 
phosphorylation influences PDZ domains, proteomic work suggests that phosphorylation 
in PDZ core or flanking sequences is relatively common. As collected in the UniProt 
database (www.uniprot.org), numerous phosphorylation sites have been experimentally 
confirmed (mostly in murine proteins) for the PDZ proteins Zo-1, GRIP1, MAGI2, 
MAGI3, and Par3, for example. Many of these phosphorylation sites exist in short 
“linkers” between domains, as observed here in PSD-95, but also within the PDZ 
domains. 
2.4.2 Phosphorylation at Y397 allosterically regulates C-terminus 
binding  
 
We successfully phosphorylated at Y397, a construct of PDZ3 that includes an α-
helical C-terminal extension that ends at position 402. A combination of chemical shift 
analysis, amide hydrogen exchange, and 15N relaxation showed that phosphorylation 
partially undocks the α3 helix from the PDZ3 core. The chemical shifts (Figure 2.4) 
convincingly show that p397-PDZ3 exists as a rapid equilibrium between a docked state in 
which α3 is natively packed (~50%) and an undocked, unfolded state (~50%). This 
conclusion was only possible because of previous work on Δ7ct, which eliminates native 
α3 by truncation of residues 396-402 [63]. In that study, α3 was shown to confer a 21-
fold increase in binding affinity to CRIPT peptide. Without α3, the PDZ3 core has 
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enhanced side-chain dynamics which are quenched upon CRIPT binding. This confers an 
entropic penalty to binding, which was detected through isothermal titration calorimetry. 
Interestingly, because α3 does not contact CRIPT peptide, this was considered a novel 
“dynamic” allosteric mechanism. Here, we show that this dynamic mechanism has 
biological significance and is minimally induced by phosphorylation at Y397. The 4-fold 
reduction in CRIPT binding affinity (as opposed to 21-fold) is consistent with the 50% 
population of unfolded α3. The behavior of p397-PDZ3 also confirms that Δ7ct serves as 
an excellent proxy for phosphorylated PDZ3 constructs. 
2.4.3 Phosphorylation tunes interdomain interactions in the PDZ3-SH3-
GK MAGUK core 
 
A caveat of the results on p397-PDZ3 (residues 304-402) here is that the construct 
remains artificial as an excised domain. One reason in support of using this construct is 
that phosphorylation at Y397 became less efficient upon further extension of the C-
terminus (data not shown). Nevertheless, the role of the linker may be important. 
Although there is no crystal structure of full-length PSD-95 or the PDZ-SH3-GK 
supradomain from any MAGUK, there is evidence for interaction between PDZ3 and 
SH3-GK. From electron microscopy, intact PSD-95 appears as a “C-shaped” arrangement 
of domains [21]. In other work, binding assays on various constructs of PSD-95 family 
MAGUKs suggest interdomain allostery between PDZ3 and the SH3-GK module. In the 
case of PSD-95, PDZ3 (as well as PDZs 1 and 2) was shown to influence binding of 
Map1a, which binds to the GK domain [28]. In the case of the PSD-95 homologue Dlg1 
from drosophila, PDZ3 influences binding of GukHolder, which binds to the SH3 
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domain [29]. Structural insight into how PDZ3 and its following linker interact with SH3-
GK is needed to unravel the basis for these interactions and how they are regulated.   
To gain insight into how PDZ3 interacts with SH3-GK and whether 
phosphorylation plays a role, we studied a PDZ3-linker-SH3 construct. 15N T2 
measurements within the PDZ3 domain for wild-type, as well as for a Y397E 
phosphomimic and a triple phosphomimic construct, Y397E/S415E/S418E. S415 and 
S418 have also been confirmed to be phosphorylated [31, 32], and therefore a 
combination of these sites may be phosphorylated under different signaling and cell 
contexts.  Phosphorylation at Y397 increased the mobility of PDZ3, and this effect was 
increased further for the triple mutant (Figure 2.7). This is consistent with a model in 
which PDZ3 interacts with SH3-GK via the SH3 domain and phosphorylation at 397 in 
α3 and 415/418 in the linker disrupt this interaction (Figure 2.8). To our knowledge, these 
are the first reported physical data that relate PDZ3 to SH3 for any MAGUK; there are no 
reported structures for any construct containing PDZ3 and SH3 domains, although 
structural models of PDZ3-SH3-GK have been proposed [120]. The T2 results suggest 
that additive phosphorylation interferes with the putative PDZ3-SH3 interaction. It is 
currently unknown in which order these three sites are phosphorylated, but it is possible 
that phosphorylation of S415/S418, which are seated in a putatively flexible fragment 
(SSLGSG), precedes phosphorylation of Y397 which is mostly buried. Phosphorylation 
of S415/S418 may then facilitate Y397 phosphorylation by loosening the domain packing 
between PDZ3 and SH3, or providing binding sites for the kinase that phosphorylates 
Y397. Overall, our NMR relaxation measurements suggest that phosphorylation of Y397, 
S415 and S418 cooperate together to regulate inter-domain communication of PSD95. 
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It is currently unclear how conserved these phosphorylation events are. The PSD-95 
family of proteins is comprised of PSD-95, PSD-93, SAP97, and SAP102. Although 
there is high sequence conservation in the α3 and linker among these proteins, 
phosphorylation at Y397 has only been confirmed for PSD-95 and PSD-93, and 
phosphorylation at 415/418 has only been observed so far in PSD-95. While it may be 
possible that differences in phosphorylation patterns in this region contribute to 
functional differences between these MAGUKs (which also have functional 
redundancies), this issue may not be clear until more in-depth phosphorylation mapping 
is carried out. 
 
Figure 2.8: Schematic explanation of function of Y397, S415 and S418 phosphorylation in PSD-95. The 
third α-helix is unfolded upon phosphorylation, which consequently interrupts the domain packing between 
PDZ3 and SH3. 
 
2.5 Concluding remarks 
 
PDZ domains are primarily appreciated for their simple function of binding C-
terminal sequences. However, PDZs are typically embedded in lengthy protein sequences 
characterized by multiple other structured domains and significant stretches of unknown 
structure/flexibility. Understanding native PDZ function therefore often requires 
consideration of these additional elements. There are now a number of examples of PDZ 
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domains whose core structures are augmented by N- or C-terminal, and a recent review 
predicts that one-third of PDZ domains contain such structural augmentations. We show 
here that the effects of such additional segments can be dynamically modulated by 
phosphorylation, which builds upon previous work that showed that the external 
segments can regulate PDZ function. In many multidomain proteins, the role of 
interdomain linkers is not well understood. By mimicking phosphorylation at Y397 and 
in the linker of the PDZ3-linker-SH3 construct from PSD-95, we detected progressive 
increases in mobility in PDZ3 due to linker phosphorylation. This suggests that the linker 
plays a key role in supradomain assembly. We propose that linkers in MAGUKs and in 
other PDZ proteins can adopt varying degrees of structure\flexibility that serves to tune 
interdomain communication. 
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Chapter 3 
NMR study of allostery within PSD-95 
 
3.1 Introduction 
 
Cell signaling is of central importance for all cellular activities, from cell division 
and metabolism to programmed death. In metazoa, one of the protein families fulfilling 
cell-cell communication is known as membrane associated guanylate kinases (MAGUKs), 
whose function is to organize signaling complexes at cell or synaptic junctions[17, 121]. 
As a sophisticated type of cell communication, neuronal signaling is transmitted by a 
highly specialized apparatus, the synapse. The MAGUK subfamily responsible for 
stabilizing the neuron synaptic junction is known as the postsynaptic density proteins 
(PSD) or PSD-MAGUKs, which contain four homologues, PSD-95, SAP97, SAP102 and 
PSD-93[121, 122]. These proteins have the same domain architecture characterized by 
three PDZ domains (PDZ1-3), an SH3 and GK, of which the C-terminal three domains, 
PDZ3-SH3-GK, comprise the MAGUK core shared throughout MAGUK family[121]. 
All four PSD proteins are highly enriched in the central nervous system [122, 123], and 
share similar spectrum of binding specificities, but they are distributed at different cell 
compartments and expressed at different stages of neuron development. For example, 
PSD-95 and PSD-93 are concentrated in the post-synaptic density and expressed at a later 
stage, while SAP97 and SAP102 are mainly found in dendrites and axons, expressed at 
early stages of neuron development [6, 124].  
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The functions PSD-MAGUKs are involved in synapse genesis, organization, 
stability, and membrane protein trafficking[121]. Malfunctions of MAGUK proteins have 
been found to be related to reduced performance in learning and memory, Alzheimer’s 
Disease, and Huntington’s Disease[125]. Due to the vital functions conferred and 
multiple diseases implicated, MAGUK proteins have drawn attention as a promising 
pharmacological target[125]. The comprehensive understanding and pharmaceutical 
relevance of MAGUK proteins requires studies at the structural level. 
Currently, structural studies of PSD-MAGUK proteins are mainly focused onto 
individual domains. In summary, all five domains of PSD-95 homologue proteins are 
protein interacting modules. PDZ and SH3 domains are well known protein interaction 
modules. Interestingly, the GK domain, which is a guanylate kinase homologue, has no 
catalytic activity[126]. The guanylate binding site, as suggested by Reese et al., is used to 
accommodate protein ligands, such as MAP1A and GKAP[43]. It is therefore not 
surprising that PSD proteins are associated with so many targets and involved in so many 
functions. However, what is unknown is how the binding events of different domains are 
coordinated in an appropriate temporal sequence. What is more relevant to the function of 
signal complex organizer is how a desired signal complex is selected among large pools 
of target candidates. There is no answer to these questions yet, but some hints have 
emerged from accumulated studies.  
Interdomain allostery is a potential approach to regulation of PSD proteins. 
Several instances of interdomain allostery have been reported for PSD proteins or their 
homologues. A study on SAP97 suggests that the Hook domain of SH3 interacts with 
calmodulin[39]. Interestingly, this interaction is enhanced by the presence of PDZ 
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binding peptides, such as CRIPT and NR2B[38]. Interdomain allostery is also reported in 
PSD-95, in which association of GK with MAP1A is promoted by PDZ3 binding 
peptides, CRIPT, APC, Kv1.4 and NR2B[28]. Interdomain communication is found in a 
PSD homologue in drosophila, Dlg1[29]. In this protein, the PDZ domain is 
indispensible for interaction of SH3-GK with Gukholder, whereas the PDZ binding 
peptide abolishes the interaction between SH3-GK and Gukholder[29]. The interdomain 
allostery within MAGUK proteins implicates that binding events of different domains 
follows a strict order and interplays each other. From the perspective of evolution, the 
interdomain communication seems to be encoded into primary sequences of PSD-
MAGUKs. Compared with the canonical domains, PDZ3 and SH3 of PSD proteins are 
“modified” or “customized” in that a conserved C-terminal extension is present at PDZ3, 
and an α-helix/loop insertion, known as the Hook domain, is found in SH3. Qian et al. 
suggested that the C-terminal extension between PDZ3 and SH3 is important for 
interdomain communication of PDZ3 and SH3-GK[29]. The replacement of the linker 
region by Gly-Ser repeats ceased the allostery of PDZ3 and SH3-GK[29]. However, the 
structural basis by which this allostery exists is still unknown.  
Considering the critical roles of PSD-MAGUKs in synapse function, it is 
expected that this family of proteins is under tight regulation. Two dominant approaches 
of PSD-MAGUK regulation are at working via palmitoylation and phosphorylation[121]. 
In PSD-95, palmitoylation transfers a fatty acid group to the N-terminal Cys3 and Cys5, 
and is related to dimerization of PSD-95[24, 25]. Phosphorylation of PSD-MAGUKs, 
however, is observed throughout the entire primary sequence[121]. Of relevance to this 
research, many phosphorylation sites of MAGUKs are located at the linker regions of 
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subdomains. For example, Ser295 located at PDZ2/PDZ3 linker of PSD-95 is 
phosphorylated. It has been suggested that phosphorylation of Ser295 regulates the 
expression level of PSD-95[127]. In SAP97, phosphorylation of PDZ2/PDZ3 linker 
disrupts the association of GK with GKAP[45]. In PSD-95, another hot phosphorylation 
region is the PDZ3/SH3 linker, where Y397, S415 and S418 are phosphorylated. In the 
previous chapter, we suggested that phosphorylation of these sites increases domain 
flexibility of PDZ3 and SH3, indicating a disruption of domain packing.  
Because of the multiple domain and linker involved, the structural mechanism of 
interdomain allostery and phosphorylation regulation of PSD proteins cannot be 
understood by the divide-and-conquer strategy used on excised domains. Of the few 
structural studies on tandem domain of PSD proteins, the role of the PDZ3 domain was 
always neglected, although the PDZ3 domain is known as an indispensible component of 
MAGUK core [43, 44]. In this research, we have studied the structure and dynamics of 
PSD-95, in an attempt to understand the PDZ-nonPDZ interaction. We first determined 
the orientation of PDZ3 relative to SH3 using PRE and chemical shift perturbation. We 
further find that CRIPT binding changes the relative orientation of PDZ3 and SH3. 
Consistent with reported results, the replacement of the PDZ3/SH3 linker reorientates 
PDZ3 relative to SH3 in the same way as CRIPT binding. Finally, SAXS data on PDZ3-
SH3-GK were used to build the structure of the MAGUK core. The SAXS model 
suggests PDZ3 is docking to the SH3 region adjacent to the Hook domain, which is 
consistent with our study on PDZ3-SH3 construct. We also monitored the motions of 
Hook domain, and infer the function of Hook in mediating allostery between PDZ3 and 
GK domain. Finally, we carried out Rosetta simulations to obtain higher resolution 
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structural models of the MAGUK core. We found that PDZ3 binds the PDZ3/SH3 linker, 
which brings PDZ3 close to SH3. 
3.2 Experimental Procedures 
3.2.1 Plasmid constructs. 
 
Rat PSD-95 with the first 60 residue truncated (61-724) was used as a template to 
make all constructs of this study. All constructs were sub-cloned into a pET21a vector 
with a TEV cleavable N-terminal histidine tag. The amino acid sequences of all 
constructs are as following: PDZ3-SH3-F (304-530 plus F strand 712-724, which is 
connect to rest part of PDZ3-SH3 by 3 GS repeats), SH3-GK (430-724) and PDZ3-SH3-
GK (304-724). To prepare constructs for PRE experiments, undesired native cysteines 
were mutated to serines by quick change mutagenesis PCR. The cysteines were 
reintroduced into desired sites for MTLS labeling purpose. The constructs for MTSL 
labeling were PDZ3-SH3-F C445C, PDZ3-SH3-F W507C, PDZ3-SH3-F W499C, PDZ3-
SH3-FΔ1Δ2 (in which two regions corresponding to EYSRFE and LMNSSLGSGTASLR 
were replaced by GS repeats), PDZ3-SH3-GK C445C, PDZ3-SH3-GK Y604C and 
PDZ3-SH3-GK S699C. 
3.2.2 Protein expression and purification. 
 
Transformed E. coli BL21 (DE3) cells were grown at 37 °C in LB medium or 
minimal medium containing appropriate isotopes. When cell density reached an OD600 of 
0.6, IPTG was added to a final concentration of 1 mM and the cells were grown for 
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another 16 hours at 22 °C. The cells were harvested by centrifugation and stored at -
80 °C until use. 
All proteins were purified using the following protocol. The cell pellets were re-
suspended in 50 mM Tris-HCl, pH 8.0, 200 mM NaCl, 0.1% triton X-100, 25 mM 
imidazole and 1 mg/ml lysozyme. The re-suspended cells were subjected to three freeze-
thaw cycles and applied to sonication. The centrifuged cell lysate was loaded to a nickel 
affinity column and eluted with 500 mM imidazole. The fractions containing proteins 
were pooled and subjected to overnight TEV cleavage at 4 °C. TEV was added to a final 
concentration of 25 μg/ml. A 100% cleavage was achieved as suggested by SDS-PAGE. 
The cleaved sample were further purified by Source Q ion exchange chromatography, 
followed by a G75 size exclusion column equilibrated in a buffer containing 50 mM Tris-
HCl, pH 7.5, 200 mM NaCl and 2.0 mM DTT. The identity and purity of proteins were 
verified by SDS-PAGE. The protein concentrations were determined by UV using 
extinction coefficients obtained by ExPASy-ProtParam tool. 
3.2.3 Peptide synthesis. 
 
The 7-mer CRIPT peptide (Ac-NYKQTSV-COOH) was synthesized and purified 
as reported [63]. The identity and purity of the peptide are verified by mass spectroscopy. 
The peptide concentration is determined using UV with an extinction coefficient of 1490 
cm-1M-1.  
3.2.4 NMR experiments. 
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All NMR samples, except those for PRE measurement, were dissolved in 50 mM 
Tris-HCl, pH 7.5, 200 mM NaCl, 2 mM DTT and 10% D2O. The proteins for PRE 
measurements were dissolved in the same buffer without DTT. MTSL labeled samples 
were prepared by mixing appropriate proteins with MTSL in a protein: MTSL ratio of 1:5. 
The mixture was placed at 4 ⁰C for overnight or room temperature for 2 hrs. Surplus 
MTSL was removed by loading sample to a size exclusion column Sephadex G25. The 
MTSL labeled protein samples were concentrated to 0.4 mM. The diamagnetic samples 
were made by adding 5 μl of 1M ascorbic acid stock solution into paramagnetic samples. 
Paramagnetic and diamagnetic spectra were recorded on a 600 or 700 MHz magnet 
equipped with 1H/15N/13C probe and z-axis pulsed field gradient. Proton transverse 
relaxation rates of paramagnetic and diamagnetic states were measured using pulse 
sequence as reported [78, 128]. The delays were set to 0.013, 0.02, 0.03 and 0.04 s-1. The 
pure PRE rates were calculated by subtraction of diamagnetic rates from paramagnetic 
rates. All NMR spectra were processed by NMRPipe and analyzed by NMRViewJ.  
3.2.5 Small angle X-ray scattering experiments. 
 
Protein samples for SAXS experiments were exchanged into a buffer containing 
50 mM Tris-HCl, 200 mM NaCl, 5 mM DTT and 1.25% glycerol by 48 hours dialysis. 
All samples were prepared at least at three different concentrations ranging from 0.5 to 4 
mg/ml to detect subtle aggregation or oligomerization. SAXS data for PSG were 
collected at protein concentrations of 0.84, 1.68, 2.69 and 5.64 mg/ml. The dialysis buffer 
was used for background scattering. SAXS data for CRIPT bound PSG were collected at 
concentrations of 0.81, 1.61 and 3.55 mg/ml. CRIPT peptide (Ac-NYKQTSV-COOH) 
was added into PSG samples to a final concentration of 0.5 mM. The protein-peptide 
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mixture was applied to a spin column with a 10 kD molecular weight cut-off membrane. 
The filtration solution from the spin column was put back to upper reservoir and repeated 
two times to wash the membrane. Then the filtration solution was used as blank for 
SAXS scattering. SAXS data of SG were collected at concentrations of 0.70, 1.71 and 
2.84 mg/ml. The samples were centrifuged for 5 minutes at 13000 rpm immediately 
before scanning. The data were collected at 12ID-B at Advanced Photon Source using a 
wavelength of 1.033 Å. Each sample was scanned 20 times with 10 seconds exposure for 
each shot. No radiation damage was detected during scanning. The buffer subtraction was 
performed using PRIMUS, and the coefficient for buffer subtraction is given by 1 cφ− , 
where φ  is the protein partial specific volume (0.0073 cm3/g)[129] and c is protein 
concentration in mg/ml. The Guinier analysis was performed using autorgqw in Atsas up to 
region Rgq 1.3[130].  
The model of PDZ3-SH3-GK was built using the ensemble optimization method. 
The SAXS data collected at lowest concentrations (0.84 mg/ml and 0.81 mg/ml for apo 
and CRIPT bound PSG) were used to carry out modeling. The crystal structures of PDZ3 
(1BFE, residue 304-402) and SH3-GK (1KJW, residue 430-724) were used as input 
domains for EOM. The region between PDZ3 and SH3, residue 403-429 was treated as a 
flexible linker. 10,000 structures were first generated by RanCh, and the following 
genetic algorithm was carried out by GAJOE to select the ensemble which fits the 
experimental SAXS data best [86].  
3.2.6 Rosetta molecular dynamics simulation. 
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 To build a PDZ3-SH3-GK structural model, FloppyTail protocol in Rosetta 
framework was used[131]. During the modeling process, unambiguous and ambiguous 
constraints were used. Unambiguous distance constraints were derived from the proton 
transverse PRE rates measured with PSG C445 and PS W499C MTSL labeling. The 
bleached resonances or these with low para- and dia-magnectic intensity ratios 
(Ipara/Idia<0.15) were assigned an upper distance of 12 Å. The distances were calculated 
using SB equations. The errors in distance constraints were derived either from the errors 
in transverse relaxation rates, or arbitrarily assigned to be ± 4 Å, whichever were larger. 
Ambiguous constraints were from the residues on PDZ3 experiencing chemical shift 
perturbations. These residues must be in vicinity of the residues from the PDZ3/SH3 
linker or SH3-GK, to incur chemical shift perturbation. Only solvent exposed residues in 
the PDZ3/SH3 linker and SH3-GK are competent candidates for PDZ3 docking. The 
solvent accessibility of residues on SH3-GK was analyzed using NACCESS [132, 133], 
and only those with solvent exposed surface area >10% were selected. The ambiguous 
constraints have an upper boundary of 7 Å.  
 The PDZ3 crystal structure (1BFE, 304-402) and the SH3-GK crystal structure 
(1KJW, 430-724) were used in modeling. In the PDZ3 crystal structure, the third α-helix 
end at residue A402. Our chemical shift data of long PDZ3 construct (304-427) indicate 
that the α-helix end K403. Therefore, we extended helicity to K403 by constraining 
backbone Cα position of K403. With all these constraints, 5,000 structures were generated 
and the 20 best scored structures were analyzed. 
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3.3 Results 
3.3.1 PDZ3 is adjacent to SH3 in tertiary structure and brought away 
by CRIPT peptide binding. 
 
At the end of Chapter 2, I showed that the mutations (Y397E, S415E and S418E) 
in the linker region of PDZ3/SH3 increase the T2 relaxation time, suggesting that 
perturbation of the linker region promotes interdomain flexibility. This result hinted that 
there must be some interdomain packing between PDZ3 and SH3 to be disrupted. The 
most straightforward way to confirm interdomain packing is to compare the chemical 
shifts of PDZ3-SH3 tandem with isolated PDZ3 domain. The interdomain packing 
perturbs chemical shifts of the residues located at the domain interface. With the  
 
Figure 3.1: Minimal chemical shift perturbation on PDZ3 by PDZ3-SH3 packing. (A) The histogram of 
minimal chemical shift perturbation. (B) Mapping of minimal chemical shift perturbation onto PDZ3 
structure. The magnitudes of CSP were shown in color scale from gray (small) to red (large). The PDZ3 
resonances in PDZ3-SH3 construct were assigned based on isolated PDZ3427 assignments. The residues 
with chemical shift changes were assigned by moving PDZ3 peaks to the nearest ones. The chemical shift 
perturbation values were calculated using 0.1|Δω15N|+ |Δω1H|. 
 
chemical shift assignments of PDZ3 available, we plot the chemical shift perturbation by 
comparing isolated PDZ3 with PDZ3 coupled with SH3. As shown in Fig. 3.1, the 
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chemical shift changes caused by presence of SH3 are mainly located around PDZ3 
peptide binding groove and the β2/β3 loop.  
 To further probe the interdomain packing of PDZ3 and SH3, we employed 
paramagnetic relaxation enhancement (PRE). Compared with the NOE, which provides 
short distance information (< 6Å), the PRE allows detection of long distance constraints 
up to 25 Å. The PDZ3-SH3 tandem only has one native cysteine, C445, which is solvent 
accessible, making it suitable for MTSL labeling. We collected a “paramagnetic” HSQC 
spectrum of PDZ3-SH3 with MTSL labeling, and diamagnetic HSQC spectrum with 
MTSL quenched by ascorbic acid. Because the two spectra were acquired at the same 
protein concentration using identical parameters, the intensity ratios of para- and 
diamagnetic spectra is reciprocally correlated to the PRE, and positively correlated to the  
 
Figure 3.2: PRE perturbation on PDZ3 by C445 MTSL labeling of PDZ3-SH3. The magnitudes of PRE 
perturbation on PDZ3 with C445 was labeled by MTSL. (A) apo PDZ3-SH3 (B) CRIPT bound PDZ3-SH3 
(C) PDZ3-SH3-Δ1Δ 2. The magnitudes of PRE are shown using color scale from gray (small) to red (large). 
The magnitudes of PRE were calculated by 1-Ipara/Idia. The residues whose data are unavailable are shown 
green. 
 
distance between the labeling site and the amide of interest. Here we define the intensity 
ratio of para- and diamagnetic spectra as “PRE”. Labeling of C445 mainly perturbs the 
PDZ3 peptide binding groove, which is consistent with the chemical shift perturbation 
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analysis (Fig. 3.2). Subtle perturbation is also observed at the opposite side of the PDZ3 
peptide binding face, which may result from the domain flexibility of PDZ3-SH3. These 
results suggest that PDZ3 is adjacent to SH3 and its peptide binding groove is facing SH3 
domain. 
 The interdomain allostery between PDZ3 and SH3 was reported in a study on 
PSD-95 homologue in drosophila, Dlg1, in which interaction between SH3-GK and 
Gukholder was abolished by the presence of PDZ3 binding peptides, CRIPT and 
neuroligin. The mechanism of this interdomain allostery was not investigated. Herein, we 
investigated the impact of CRIPT binding on the PDZ3-SH3 interaction. Using the above 
method, we collected para- and diamagnetic spectra of PDZ3-SH3 in the presence of 
CRIPT peptide. We found that, upon CRIPT binding, the PRE effect that was observed 
around the PDZ3 peptide binding groove for apo PDZ3-SH3 disappeared, as shown by 
Fig. 3.2B. The difference in peak intensity ratios (IparaCRIPT/IdiaCRIPT -IparaAPO/IdiaAPO) for 
apo and CRIPT bound PDZ3-SH3 is also shown in Fig. 3.3A and 3.3B. The large 
positive differences are around the peptide binding groove (Figure 3.3 A, B), suggesting 
this side becomes further from the SH3 domain, while some subtle negative values, 
whose magnitudes are smaller than the positive ones, are found at the opposite of the 
peptide binding groove. It is clear that CRIPT binding tends to move the peptide binding 
face of PDZ3 away from SH3.  
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Figure 3.3: PRE perturbation changes by the CRIPT peptide binding (A, B) and the PDZ3/SH3 linker 
replacement (C, D). The gradient of color scales in B and D is from blue to red, corresponding to the 
negative to positive values of A and C. 
 
 As suggested by the study on Dlg1, the interdomain allostery of PDZ3 and SH3 
was also disrupted by deletion or replacement of PDZ3-SH3 linker region by random coli. 
To quantify the impact of the linker replacement, we made a PDZ3-SH3 construct in 
which two fragments in linker region were replaced by Gly-Ser repeats. As shown by Fig. 
3.2C and 3.3B, the disruption of the PDZ3-SH3 linker region moves PDZ3 away from 
SH3, similar to the effect of CRIPT peptide binding. The effects of CRIPT peptide 
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binding and linker region replacement on PRE pattern suggest that two events share a 
similar way to affect interdomain interactions between PDZ3 and SH3.  
 
Figure 3.4: HSQC peak intensity statistics of PDZ3-SH3-GK. The PDZ3 resonances were assigned based 
on isolated PDZ3. The residues that were not assigned in the spectrum were assumed to be from SH3/GK 
domain. The black bars indicate the average peak intensities of PDZ3 (0.21) and SH3-GK (0.80). 
 
3.3.2 PDZ3 does not form stable and static complex with SH3-GK. 
 
The above studies on PDZ3-SH3 showed that the peptide binding groove of PDZ3 
faces the SH3 domain. Still unknown is the relative orientation between PDZ3 and GK. 
To this end, we further focused our studies onto the PDZ3-SH3-GK (PSG) triple domain 
construct. From TROSY-HSQC of PSG, 330 peaks were picked out of 420 residues (Fig. 
3.4). Over 80% of the PDZ3 resonance peaks were assigned based on isolated PDZ3. 
Noticeably, the resonances of PDZ3 dominate the HSQC spectrum of PSG. As shown in 
Fig. 3.4, the average peak intensity of PDZ3 is 0.21, whereas the average value for SG is 
0.08. For static complex, individual components are expected to have similar tumbling 
70 
 
times, and consequently comparable peak intensities. This peak intensity difference 
between PDZ3 and SG suggests PDZ3 is not tightly complexed with SH3-GK (SG).  
3.3.3 PDZ3 is not docked into MAP1A binding groove. 
 
 As suggested by the previous section, domain flexibility within PSG enables 
PDZ3 to sample multiple conformations or orientation relative to SG. It is of special 
interest to know whether PDZ3 is sampling the conformation in which PDZ3 is docked 
into the MAP1A binding groove of GK, because docking of PDZ3 to MAP1A binding 
groove provides a possible mechanism by which interdomain communication between 
PDZ3 and GK is affected. To test this hypothesis, we silenced native cysteines of PSG 
(C445, C562, C626 and C687), and introduced a mutant cysteine to the MAP1A binding 
site, Y604. We labeled Y604 using MTSL, and collected paramagnetic and diamagnetic 
spectra. By comparing the peak intensities of the two spectra, no severe peak intensity 
attenuation was found on PDZ3 (Fig. 3.5). It indicates that PDZ3 is not close to MAP1A 
binding site. Thus, interdomain interaction between PDZ3 and GK must be 
communicated allosterically.  
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Figure 3.5: Intensity ratio of paramagnetic and diamagnetic spectrum of PSG Y604C. The black bar 
indicate ratio of 1. 
3.3.4 PSG Structural modeling by SAXS. 
  
 To understand the interdomain communication between PDZ3/SH3 and 
PDZ3/GK, a structural model of PSG is required. Isolated domain structures of PDZ3 and 
SG have been solved by crystallography, making it suitable for SAXS rigid body 
modeling. High quality SAXS is a prerequisite for reliable modeling results. To detect 
subtle aggregation and verify data quality, SAXS data at different protein concentrations 
were scanned (Fig 3.6 and Table 3.1). As shown by table 3.1, radius gyrations calculated 
at different concentrations yield similar values, indicating samples were well mono-
dispersed at low concentrations.  
Table 3.1: Radius of gyration at different concentrations 
PSG PSG+CRIPT 
Concentration 
(mg/ml) Rg (Å) 
Concentration 
(mg/ml) Rg (Å) 
0.8 30.5±0.1 0.81 32.1±0.8 
1.7 30.8±0.1 1.61 30.7±0.7 
2.7 30.8±0.1 3.55 31.2±0.6 
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Figure 3.6: SAXS scattering curves of apo and CRIPT bound PSG. 
 
 Since PSG may exist as a conformation ensemble, it is appropriate to fit SAXS 
data using the ensemble optimization method [86]. Crystal structures of PDZ3 and SG 
were used as input structures and the linker region was treated as a flexible loop. From 
10,000 randomly generated structures, an ensemble containing 20 structures which fit 
SAXS best was selected. The probability distribution (or sampling frequency) of radius 
gyration for apo PSG and CRIPT bound are shown in Fig. 3.7. In this plot, the integration 
of all curves is 1. The structure pools created for apo and bound PSG are essentially the 
same; however, the selected conformations of the two samples are distinct. For apo PSG, 
basically three populated species are identified: a compact conformer with Rg of 25 Å, a 
major one with medium Rg of 29.5 Å and a lowly populated extended conformer with Rg 
of 36 Å. Although the similar three conformers are also found for CRIPT bound PSG, 
there are three distinctions. First, populations of compact and medium forms for CRIPT 
bound PSG are decreased but the extended form becomes more populated. Second, the 
peak distribution of medium and extended forms are so broadened that two species 
become less distinctive. Third, relative to apo PSG, all distribution centers of CRIPT 
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bound PSG are shifted to larger values.  Fig. 3.8 shows the superimposition of 20 
structures for PSG in both states. From the structure ensemble, three clusters can be 
identified, consistent with Rg distribution. The largest cluster consisting of 13 structures is 
docked to SH3 around the Hook domain. Due to the spherical shape of PDZ3, it is 
impossible for SAXS to distinguish the orientation of PDZ3 relative to SH3-GK. The 
other important information from SAXS data is the population of different clusters, 
which is reflected by the number of structures of each cluster. In contrast, as shown in Fig. 
3.8 D and F, no clearly defined cluster can be found for the structural ensemble of CRIPT 
bound PSG. PDZ3 is evenly distributed around SH3 domain. This observation is 
consistent with what we found in the previous study on PS construct, in which CRIPT 
peptide binding somehow disrupts the domain interaction between PDZ3 and SH3. 
 
Figure 3.7: Radius gyration distributions of apo and CRIPT bound PSG.  
 
 Another interesting finding in SAXS modeling is that PDZ3 is adjacent to the 
Hook domain. This implies that the presence of PDZ3 could affect Hook domain 
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conformation, whereas CRIPT peptide binding which releases PDZ3 from SH3 may 
redistribute the conformation of the Hook domain.  
 
Figure 3.8: EOM fitting results. Apo PSG data and EOM models are shown in left column (A, C, E) and 
CRIPT bound data and fitting models are shown in right one (B, D, F). PDZ3 domain is represented by 
blue cartoons and SH3-GK by red ones.  E and F rotate 90 degrees relative to C and D. 
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3.3.5 Intradomain Flexibility of SH3-GK. 
 
 MAGUK proteins have low sequence homology in their Hook domains. It is 
inferred that the Hook domain may be the key component to differentiate functions of 
different MAGUK proteins. In the SH3-GK crystal structure, the Hook domain displays 
high B-factors and possesses few contacts with the rest part of the protein. Indeed, our 
results also suggest that Hook domain is highly flexible. Two distinctive residues in the 
Hook domain are W499 and W507, whose side-chain ε amide proton can be identified by 
high intensities and characteristic chemical shifts. We further confirmed our speculation 
by mutating these two tryptophans into cysteines individually (Fig. 3.9A). Interestingly, 
the peak intensity of W499 and W507 were dramatically attenuated by paramagnetic 
labeling of C445, Y604 or S696 (Fig. 3.9B, C, D), which are separated far away from 
each other and from W499 or W057 in the static crystal structure (Fig. 3.10).  
 As shown in Fig. 3.10, the distances between W499 or W507 and the MTSL 
labeling centers are beyond the spatial range of strong paramagnetic perturbation (25 Å). 
One possible explanation is that the Hook domain samples a large spatial range of 
conformations. W507 located on the flexible loop is able to move freely due to the lack 
of restraints. The W499, however, is located in an α-helix, whose motions are more 
restrained than W507. The distance between W499 and Y604C is 38.7 Å. It is unlikely to 
bring W499 to vicinity of Y604 by just moving W499 while keeping Y604 fixed. It is 
known that the MAP1A binding groove experiences an open-to-close transition during 
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peptide binding [43]. Therefore it is possible that the bleaching of W449 resonance 
results from motions of both Hook domain and GK lid domain where Y604 is located.  
 
Figure 3.9: Paramagnetic perturbations on W507 and W499. Paramagnetic and diamagnetic spectra are 
superimposed to display paramagnetic perturbation. Paramagnetic spectra were shown in red and 
diamagnetic ones in black. (A) HSQC spectra of W507C (magenta) and W499C (blue). Therefore two 
peaks were assigned as W499 and W507 respectively. Paramagnetic perturbation of the Hook domain by 
MTSL labeling of (B) C445, (C) Y604C, and (D) S696C. 
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Figure 3.10: Location of paramagnetic labeling sites. The MTSL labeling sites C445, S696C and Y604C 
are shown as spheres, and W507 and W499 are shown in green sticks.  The Hook domain is colored cyan. 
The residues responsible for MAP1A binding are colored blue. The distances between labeling centers and 
observation sites are denoted by black lines. 
 
3.3.6 Preliminary modeling results of PSG using Rosetta. 
 
 We have shown the orientation of PDZ3 relative to SH3 in a semi-quantitative 
way using PRE information, and modeling of PSG at low resolution using SAXS. 
However, the questions still remain: how does PDZ3 interact with SH3-GK and why can 
CRIPT binding change the conformational distribution of PSG? We also want to know 
how the domain packing between PDZ3 and SH3 is disrupted by the replacement of the 
PDZ3/SH3 linker and phosphorylation of Y397, S415 and S418. To answer these 
questions, we need a high resolution structural model. 
To this end, FloppyTail protocol based on Rosetta frame was used in combination 
of unambiguous and ambiguous distance constraints. The unambiguous constraints were 
obtained from the PRE data. C445 of the PSG construct and W499C of the PDZ3-SH3 
construct were labeled by MTSL, and the PRE rates were calculated as described in 
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Chapter 1.6.3. The distances are calculated using the SB-equation, and the error range is 
estimated as described in experimental procedure. The ambiguous distance constraints 
were obtained from the chemical shift perturbations on PDZ3, as shown in Fig. 3.1. 
These residues were constrained in such a way that they are set in vicinity of 7 Å to any 
one of solvent exposed nonPDZ3 residues.  
 
Figure 3.11: Rosetta modeling of PSG. (A) Overview of PDZ3-SH3-GK. PDZ3 is shown in red, the α2 and 
β2, which constitute the peptide binding groove is shown in magentas, the PDZ3/SH3 linker in blue, SH3 
in green, the Hook domain in cyan and GK in gray. The residues on MAP1A binding groove are shown in 
blue spheres. H-bonds are shown in green dotted lines. The following panels use the same color scheme. (B) 
Docking of the PDZ3/SH3 linker into the PDZ3 peptide binding groove. The PDZ3 peptide binding pocket 
is represented by surface. Sidechains of M412 and F447 are docked into the hydrophobic pocket of PDZ3. 
(C) Interactions S415LGS418 fragment with PDZ3 and SH3. S415 forms H-bonds with S449 of SH3, and 
L416 is packed to the hydrophobic of PDZ3 formed by L342, A343, T321 and P346. D464 and D467 
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around S418 are shown in green sticks. (D) Sequestration of the Hook domain. Basic residues on the Hook 
domain are shown in cyan sticks. A H-bond is formed between the linker residue E409 and the Hook 
domain residue R501.   
 
 Typically, 5,000 structures were calculated by FloppyTail, and the 20 best scored 
structures were analyzed. Fig. 3.11 shows a representative of PSG modeling results. The 
most interesting finding in this model is that the PDZ3 peptide binding groove is sealed 
by the PDZ3/SH3 linker. A highly conserved residue M412 is docked into the 
hydrophobic patch of PDZ3. Canonically, this hydrophobic patch accommodates the 
hydrophobic C-terminus of PDZ3 binding peptides. This hydrophobic pocket is further 
filled by the sidechain of F449. Similar to the canonical PDZ-peptide interaction, a 
network of H-bonds is weaved between S414-G322, M412-N326, E331-R408 and R501-
E409. It is noteworthy that this internal peptide binding mode is short of the H-bonds 
formed between the C-terminus carboxyl group and the binding pocket. Therefore, the 
binding between PDZ3 and the PDZ3/SH3 linker is expected to be weaker than the 
canonical PDZ-peptide interactions. The binding of PDZ3 to the PDZ3/SH3 linker 
shortens the linker and therefore brings PDZ3 closer to SH3. More importantly, binding 
of CRIPT peptide expels the PDZ3/SH3 linker from the binding groove and consequently 
disrupts the domain association of PDZ3 with SH3/GK. 
 Another interesting finding in the PSG model is that the S415LGS418 fragment, 
which bears two in vivo phosphorylation sites S415 and S418, interacts with both PDZ3 
and SH3. S415 forms H-bonds with S449, and L416 is docked to a hydrophobic of PDZ3 
formed by L342, A343, T321 and P346. In the vicinity of S418, there are two negatively 
charged residues D464 and D467. In the previous chapter, we showed that 
phosphorylation of S415/S418 disrupted domain packing of PDZ3/SH3. It is possible that 
80 
 
when S415 and S418 are phosphorylated, the H-bond between S415 and S449 is broken 
and the phosphoryl group of phosphoS418 creates a repulsive force against the negative 
charge cluster of D464 and D467. All these perturbations destroy the interaction between 
SLGS linker and SH3, and consequently promote domain flexibility. 
 This model also suggests that the Hook domain is involved into PDZ3 and SH3 
association. A hydrogen bond is form between E409 of the PDZ3/SH3 linker and R501 
of the Hook domain. The calmodulin binding face of the Hook domain consists of 
positively charged residues. As shown in Fig. 3.11D, those residues are sequestered by 
PDZ3 and the PDZ3/SH3 linker.   
3.4 Discussion 
 
 Biological functions of PSD-95 and other MAGUK proteins have been 
intensively studied for the last two decades. Overall, PSD-95 has been found to associate 
with numerous targets, performing diverse biological functions. One can imagine that 
more PSD-95 target proteins and functions will be identified. The extensive interaction 
and functional spectrum of PSD-95 is feasible considering that all component domains of 
PSD-95 are protein interacting modules. Thus, PSD-95 can fulfill its function as a 
scaffold by integrating multiple protein interacting domains into one amino acid chain. 
However, it is illusive how PSD-95, as a signaling organizer, ensures the binding events 
of different subdomains to take place in the proper context, which is usually required for 
the directionality of cellular signaling, and how PSD-95 ensures a signaling complex to 
contain the right combination of target molecules, which is required for fidelity of 
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cellular signaling. To answer these questions, insight into interdomain communication 
and allosteric regulation of PSD-95 is needed.   
3.4.1 Interdomain contacts between PDZ3 and the Hook domain 
 
 Here, we integrate PDZ3 into our study of PSD-95, and find that PDZ3 forms a 
dynamic complex with SH3-GK. Chemical shift perturbation and PRE data suggest that 
the peptide binding groove of PDZ3 faces SH3. This orientation of PDZ3 relative to 
SH3-GK is changed by CRIPT peptide binding, as indicated by PRE. Our SAXS data 
suggest PDZ3 is mainly docked to the Hook region of SH3 domain. The Rosetta model 
also indicates that the PDZ3 masks the basic amino acids of Hook domain, which is a 
known calmodulin binding face. Moreover, CRIPT binding redistributes PDZ3 around 
the SH3 in a random pattern. These results hint at the complex allosteric mechanism 
between CRIPT binding of PDZ3 and Hook/calmodulin interaction[38]: Docking of 
PDZ3 around the Hook domain sequesters binding sites for calmodulin interaction or 
renders the Hook domain in a conformation unsuitable for calmodulin binding. Whereas 
binding of CRIPT releases PDZ3 from the SH3/Hook region, enabling the Hook domain 
to adapt a conformation for calmodulin interaction.  
3.4.2 The Roles of the PDZ3/SH3 linker 
 
 The linker region of PDZ3/SH3 is conserved throughout different MAGUK 
proteins. In this research, we replaced two fragments of the linker region with Gly-Ser 
repeats, which are expected to lack stable structure. Our PRE data suggest that 
replacement of the linker region results in the disruption of PDZ3/SH3 domain 
orientation. This result is consistent with, and correlates to interdomain allostery of 
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binding groove. It is noteworthy that the binding of the PDZ3/SH3 linker to the PDZ3 
binding groove is different from canonical PDZ-peptide interaction. In canonical PDZ-
peptide interaction, both hydrophobic contact and extensive H-bonding interactions are 
present. From the complex structure of PDZ3 and CRIPT (Fig. 1.1), 9 H-bonds are found. 
However, the interaction between C-terminus PDZ3/SH3 linker and PDZ3 is mainly 
mediated by hydrophobic packing and 4 hydrogen bonds. This may explain why a 
dynamic ensemble, instead of static and stable association of PDZ3 with SH3-GK is 
obtained.  
According to the Rosetta modeling results, the linker region is further rigidified 
by interaction of S415LGS418 with PDZ3 and SH3. This interaction is mediated by 
hydrophobic packing of L416 with PDZ3 and hydrogen bond between S415 and S449 
(Fig. 3.11C). Around these two residues, negatively charged residues, D464, D467 are 
found. Phosphorylation of these residues incurs electronic repulsion and breaks the H-
bond, which is consistent with the increased domain flexibility suggested in the previous 
chapter.  
3.4.3 Allostery of PDZ3/GK and putative function of Hook domain 
 
 Based on our PSG models built by SAXS and PRE data, PDZ3 is far away from 
the MAP1A binding groove located in the GK domain. Although the mechanism by 
which PDZ3/GK allostery is carried out is still elusive, our data provide a hint at this long 
distance interdomain allostery. We speculate that the Hook domain is a putative 
candidate to transfer the interdomain communication between PDZ3 and GK. A 
tryptophan at the Hook domain (W507) experiences strong paramagnetic perturbation 
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when C445, Y604C or S696C were labeled by MTSL. C445 is near to the PDZ3 docking 
site, while Y604 is at the MAP1A binding groove. These results indicate Hook domain is 
sampling various conformations spreading from MAP1A binding site to the PDZ3 
docking site. Moreover, the strong PRE on W499 suggests that to create the paramagnetic 
perturbation, the lid domain of GK also has to adjust its conformation. It is known that 
binding of MAP1A requires the large scale transition of GK lid domain from open to 
close conformation. This conformational transition could be synchronized with Hook 
motions. A recent study suggested that mutations in the Hook domain and hinge of Hook 
domain  results in a continuous activation of GK[44]. This study indicates the presence of 
an allosteric pathway between SH3 and GK. As suggested by research herein, the 
conformation of the Hook domain could be modulated by PDZ3. It is reasonable to 
speculate that allosteric information can be transferred to GK from PDZ3 via the Hook 
domain. From an evolutionary perspective, the sequence divergence of four PSD-
MAGUKs, i.e. PSD-95, SAP97, SAP102 and PSD-93 in neuron cells mainly occur 
within the Hook domain. Except for this sequence difference, binding specificities of 
PSD-MAGUKs identified by excised domains are very similar. It is possible that the 
Hook domain is a key component to differentiate PSD-MAGUKs. The putative 
regulatory role of the Hook domain may therefore endow different members of MAGUK 
family with different outcomes.    
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Chapter 4 
Crystallographic and NMR evaluation of the 
impact of peptide binding to the second PDZ 
domain of PTP1E 
 
4.1 Introduction 
 
The PDZ (PSD95/Discs large/ZO-1) domain family is one of the most abundant 
protein interacting modules found from bacteria to humans, with over 200 PDZ domains 
encoded in the human genome [5-7]. While they influence diverse functions in the cell, 
they are typically involved in targeting and assembly of multiprotein signaling complexes 
at synapses or other membrane proximal loci. PDZ domains fulfill this function through 
their facility in binding C-termini sequences (4-7 amino acids) of target proteins. They 
are often found in tandem arrays within a PDZ-containing protein, consistent with their 
role as scaffolds for association with membrane receptors, enzymes and ion channels [6]. 
They share a common fold, consisting of 2 α-helices and 6 β-strands, with the second α-
helix (α2) and second β-strand (β2) forming the canonical peptide binding groove [13].  
In addition to scaffolding, numerous studies indicate that PDZ domains can have 
more direct regulatory functions. In particular, a subset of PDZs has now been 
characterized as displaying allostery [14, 63, 95, 96, 134, 135]. This is exemplified by the 
PDZ domain from Par6, which, upon binding CDC42 to the adjacent semi-CRIB motif 
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contacting the PDZ at an interface away from the peptide binding groove, undergoes a 
conformational change at the binding groove [14]. There is also recent evidence for 
interdomain allostery with PDZs [29, 135, 136]. Thus, while all PDZs have the capacity 
to serve as “passive” scaffolds, at least a subset appear to possess higher-order functional 
roles [137]. A central question in the PDZ field is, what distinguishes allosteric PDZs 
from simple scaffold PDZs, and to what degree are allosteric properties conserved? 
Further, although only some PDZs have “active” functions, are some properties related to 
these functions found in all PDZs because they either derive from a common descendent 
or those properties are intrinsic to the PDZ fold? Interestingly, although many PDZ 
structures have been determined in the absence and presence of ligands, observations of 
large conformational changes in PDZ domains have been rare [119]. Thus, much of the 
exploration of potential allosteric effects in PDZs has focused on more subtle origins than 
gross conformational change (see below). 
As a result of such questions, during the last decade PDZ domains have been 
selected for biophysical study of their internal signaling properties. In 1999, Ranganathan 
and coworkers used sequence co variation analysis to reveal an evolutionarily conserved 
energy transmission pathway that connected to a key residue in the peptide binding site 
[138]. Specific PDZ domains were subsequently tested for intramolecular energy 
propagation using perturbation-response approaches [2, 3, 139], and analogous 
computational methods were developed that revealed PDZ-specific communication 
pathways [140-144]. These studies demonstrated that perturbation at localized positions 
in PDZ domains cause changes in dynamic fluctuations that propagate to more distal 
regions of the domain. They also have typically focused on two specific PDZ domains: 
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PDZ3 from postsynaptic density-95 (PSD-95), and PDZ2 from the protein tyrosine 
phosphatase PTP1E/PTPL1. Hence, “PDZ3” and “PDZ2” have emerged as the preferred 
PDZ domains for biophysical studies. Because of their representative status, gaining 
complete structural, dynamic, and biochemical information on these systems is highly 
desirable for fundamental understanding of PDZ domain function. 
Historically, long-range effects (e.g. allostery) have been associated with 
conformational change. Thus, to understand how certain PDZ domains carry out their 
active functions, it is necessary to evaluate both structural and dynamic features of these 
systems. The archetypal PDZ domain is the third PDZ domain (“PDZ3”) from PSD-95. 
Early structural studies demonstrated a lack of significant structural change upon binding 
C-terminal peptide ligand [9]. Recently, Petit et al. showed that PDZ3 is indeed allosteric 
and that the mechanism of allostery is not structural, but resides in the conformational 
entropy of side-chain dynamics [63, 145]. In the case of PDZ2 (second PDZ from 
PTP1E/PTPL1, human form), the issue of structural change upon ligand binding is less 
clear. Several NMR structures have been reported for PDZ2. Human PDZ2 was reported 
for the apo state [146] and bound to RA-GEF2 peptide [147]. Although the backbone 
RMSD (using mean structures) between these two structures is 1.3 Å, with some subtle 
shifting of α2 upon peptide binding, clear conformational changes were not mentioned 
[147]. Mouse PDZ2, which differs by 6 amino acid substitutions (mostly in loops), was 
reported for the apo state [148] and bound to the APC peptide [139]. Subtle but 
significant structural changes were found upon APC binding, with a change in the tilt of 
α2 of 10º [139]. One complication in interpreting these NMR structures is that the free 
mouse and human do not agree very well and there appear to be some statistical problems 
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with human PDZ2, as pointed out [148]. In addition, none of these structures agree well 
with residual dipolar coupling (RDC) measurements reported here. Thus, at least for 
human PDZ2 binding the RA-GEF2 peptide, the question of conformational change has 
remained unresolved. As a result, in our previous study of side-chain dynamics in PDZ2 
we concluded that a substantial role of structural changes in dynamic propagation could 
not be excluded [2]. 
In addition to the role of dynamics in intramolecular signaling in PDZ domains, 
dynamics has also been proposed to be important for PDZ domains’ binding promiscuity 
and specificity [149-152]. Specific PDZ domains can bind to different classes of peptide 
ligands, and conversely, different PDZs are known in some cases to bind the same ligand 
[153].  Still unknown is how specific PDZ domains achieve the optimal balance between 
promiscuity and specificity, an issue also important for PDZ targeted drug design [154, 
155]. The origin of PDZ binding promiscuity is an active area of research.   
Because of the popularity of PDZ2 for structure-based biophysical studies of 
folding [156-160], binding [135, 139, 151, 159], and energy transmission [2, 3, 142, 143, 
161, 162], the lack of reliable structural models for free and peptide-bound PDZ2 has 
compromised the interpretations of these studies and threatens to discourage future work 
on this model system. Without good structural information, it is impossible to weigh the 
balance of structure and dynamics in PDZ2, and, by extension, in PDZ domains. Here, 
we have determined the structural coordinates of apo and RA-GEF2 bound human PDZ2 
using X-ray crystallography to resolutions of 1.65 and 1.3 Å, respectively. The 
coordinates were found to be consistent with solution NMR RDC measurements, thus 
indicating that the structures also represent (time-averaged) PDZ2 faithfully in solution. 
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Overall, changes in PDZ2 structure upon binding RA-GEF2 peptide are very small with 
RMSD of 0.3 Å. In addition, to test the robustness of our previous finding of propagation 
of dynamic changes in PDZ2 and to gain insight into binding specificity, we also 
characterized dynamic propagation upon binding a C-terminal peptide from APC, using 
2H methyl relaxation. These results show that both RA-GEF2 and APC peptide binding 
induce highly similar long-range perturbative effects to ps-ns side-chain dynamics, and 
this propagation is not driven by structural changes. Finally, to gain insight into the 
mechanism of peptide binding, both RA-GEF2 and APC peptides were investigated for 
their binding kinetics at the site-specific level using NMR relaxation dispersion methods. 
 
4.2 Experimental Procedures 
4.2.1 Protein expression and purification.  
 
The second PDZ domain (1361-1456) from human PTP1E/PTPL1 was sub-cloned 
into pET21 vector as described [2]. Protein was overexpressed in the BL21 (DE3) cell 
line in LB or M9 minimal media. Cells transformed with PDZ2 vector were induced with 
1 mM IPTG and grown at either 22 or 37 °C overnight for protein expression. PDZ2 was 
purified using the same procedure as reported [2] and verified by mass spectroscopy. For 
crystallization, protein was exchanged into buffer containing 50 mM NaCl and 20 mM 
Tris-HCl pH 6.8. For NMR study, protein was dissolved in 150 mM NaCl and 50 mM 
sodium phosphate pH 6.8, and 10% D2O. To prepare isotope-labeled samples for NMR, 
isotopically enriched chemicals (15NH4Cl, U-13C6 (99%) D-glucose, and D2O) were used 
in the minimal media.  
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4.2.2 Peptide preparation.  
 
RA-GEF2 peptide (Ac-ENEQVSAV) was a product of GenScript (Piscataway, NJ). 
The peptide concentrations were determined by PULCON [163, 164]. APC peptide 
(GSYLVTSV) was chemically synthesized with F-MOC modified amino acids using 
solid phase methods [165]. The peptide product was purified by HPLC using a reversed-
phase C18 column and acetonitrile gradient. The identity and purity of the resultant 
peptide was checked by mass spectrometry. The APC peptide stock concentration was 
determined by UV absorbance with an extinction coefficient of 1490 cm-1M-1 at 280 nm. 
4.2.3 Crystallization.  
 
The apo and RA-GEF2 bound PDZ2 crystals were obtained using the hanging drop 
diffusion method. Apo-PDZ2 was crystallized via mixing 1.5 μl of 60 mg/ml protein and 
1.5 μl of well buffer containing 28% PEG 3350, 0.2 M KI, 0.2 M NaSCN, 0.1 M sodium 
acetic acid pH 4.5, and 5% 2-propanol at room temperature. RA-GEF2 bound PDZ2 co-
crystals were obtained in 20% PEG 3350, 0.2 M NaSCN, 0.8 M (NH4)2SO4 and 0.1 M 
sodium citrate pH 5.5 in the presence of 10 mM RA-GEF2 peptide at 4 °C. It should be 
noted that these crystallization solutions served as effective cryoprotectants. In the case 
of the complex, incomplete mixing of PEG and (NH4)2SO4 likely led to high local 
concentrations of PEG. Therefore, the crystals of free and peptide-bound PDZ2 were 
directly flash-frozen using liquid nitrogen for storage without additional cryo protection 
step. 
4.2.4 Structure determination and refinement.  
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The apo and peptide bound PDZ2 domain crystal diffraction data were collected in 
beamline X29A of the National Synchrotron Light Source at Brookhaven National 
Laboratory. Both data sets were collected with X-ray wavelength 1.0809 Å at 100 K 
(Table 4.1). Space groups were determined using xtriage [166]. The integrated and scaled 
data by HKL2000 [167] were applied to AMoRe integrated in the CCP4 package for 
molecular replacement [168]. To build the initial apo structural model, PDZ2 from 
SAP97 [169] (PDB ID: 2AWX) was used as a search model. The apo structure was 
processed further with alternating rounds of refinement by REFMAC [170] and 
phenix.refine [171] and manual model building by Coot [172]. TLS refinement with  
Table 4.1: Data collection statistics 
 Apo PDZ2a RA-GEF2 PDZ2a 
Wavelength (Å) 1.0809 1.0809 
Resolution Range (Å) 50-1.65 50-1.3 
no. of reflections 1216653 460997 
no. of unique reflections 74902 34689 
Completeness (%) 98.6 (73.6)a 99.1 (97.7) 
Space group P212121 H32 
Cell parameters (Å) 63.023 95.148 101.989 73.965 73.965 134.056 
Cell angles (deg) 90 90 90 90 90 120 
Average redundancy 16.2 (10.8) 13.3 (10.7) 
Rmerge (%) 11.4 (85.6)b 5.6 (18.0) 
<I/σ> 19.232 47.456 
a The values in parentheses are for the highest resolution shell. 
b Rmerge = Σh Σi | Ii (h) - <I(h)>|/ ΣhΣiIi(h), where Ii(h) is the intensity of an individual measurement of the reflection 
and <I(h)> is the mean intensity of the reflection.
 
 
phenix was applied with TLS parameters from the TLSMD server [173]. Densities for the 
iodine ions, which were added during the crystallization process, were characterized 
utilizing Bijvoet difference maps. For the peptide-bound structure model, the apo PDZ 
structure was utilized as a search model for molecular replacement, but without peptide 
coordinates to rule out phase bias. Peptide electron density was clearly visible after the 
first cycle of refinement and then filled with peptide model. The peptide-bound structure 
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was also processed with alternating rounds of refinement by REFMAC [170] and 
phenix.refine [171] and manual model building by Coot [172]. During refinement with 
phenix.refine, the individual anisotropic ADP refinement option was utilized. Both 
structures have weak additional electron densities occupying the non-protein space that 
are modeled with water molecules.  
4.2.5 NMR spectroscopy.  
 
All NMR experiments were carried out at 25 °C (calibrated using methanol) on 500 
and/or 600 MHz Varian Inova spectrometers. The protein concentration used was 1 mM. 
To prepare peptide saturated protein samples, RA-GEF2 or APC peptide was added to a 
peptide: protein ratio of 1.8:1. Protein concentrations were determined by UV absorbance 
with ε280=1490 cm-1M-1. All NMR spectra were initially processed by NMRPipe [174] 
and subsequently applied to NMRView [175] or in-house programs lab for further 
analysis.  
4.2.6 RDC data collection and analysis.  
 
Using the IPAP-HSQC experiment [176], 15N-1H RDC data were collected for 
isotropic and anisotropic samples on a 500-MHz magnet. Proteins were aligned by axial 
stretching of a 6-mm polyacrylamide gel (6%) into a 5-mm NMR tube (New Era 
Enterprises, Inc., Vineland, NJ) [177]. The residual dipolar couplings were extracted 
using the RDC module of NMRPipe. Q-factors of RDC data were calculated by 
REDCAT [178]. The residues in flexible loops, termini together with overlapping 
resonances were excluded in RDC data analysis. 
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4.2.7 Binding affinities and populations.  
 
The binding affinity between the RA-GEF2 peptide and PDZ2 was determined by 
fluorescence and further confirmed by NMR titration. The two methods produced the 
same Kd of 10 μM. The APC-PDZ2 binding affinity was also measured by NMR titration, 
yielding a Kd of 10 μM (Fig. S4.3). With Kd, total peptide concentration [ST], and total 
protein concentration [PT] known, the populations of peptide-bound [PB] and unbound 
PDZ2 [PA] can be calculated as: 
2/}]]][[4])[][[(])[][{(][ 2/12 TTTTDTTDB PSPSKPSKP −++−++=   (eq. 1) 
, and 
][1][ BA PP −= .         (eq. 2) 
 
4.2.8 15N Relaxation dispersion. 
 
 15N Carr-Purcell-Meiboom-Gill (CPMG) relaxation dispersion experiments were 
carried out using compensated CPMG pulse sequence [179]. For all PDZ-peptide 
complexes, time delays between consecutive 180º CPMG pulses were set as 0.556, 0.652, 
0.75, 0.936, 1.25, 1.5, 1.875, 2.5, 3, 3.75, 5, 7.5, and 15 ms. The total relaxation time in 
CPMG train was 60 ms. The RA-GEF2 bound PDZ2 relaxation dispersion data were 
acquired at two sub-saturated states with peptide: protein molar ratios of 1:19.6 and 
1:1.97, respectively. APC bound relaxation dispersion data were collected at a single 
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peptide: protein ratio of 1:19.6. The relaxation dispersion data were collected on 500 and 
600 MHz spectrometers in an interleaved manner.  
Relaxation dispersion curves were fitted both locally (residue-specific fits) and 
globally using the in-house program exrate [1]. For global fitting, a single exchange rate 
kex, a single [ ]AP , and residue-dependent Δω and R20 values were fitted using the general 
Carver-Richards expression [180]. For the sample with ~5% saturation, [ ]AP  obtained 
from global fitting was 94.7%, in excellent agreement with 94.8% based on known Kd 
and concentrations. We found that fitted Δωs agreed very well with the directly observed 
chemical shift differences between free and fully saturated PDZ2 (Δωtitration). For local 
fitting of individual residues, the [ ]AP [ ]BP  product was set as a known constant (based 
on the global fit). In the local fits, the better of the two fits between use of the general or 
“fast” models was determined based on agreement of ΔωCPMG with Δωtitration.  
4.2.9 ps-ns dynamics.  
 
Backbone and side-chain dynamics of APC-bound PDZ2 was studied in the same 
manner as for the RA-GEF2 complex reported previously [2]. Briefly, 15N backbone 
relaxation experiments were used to collect 15N T1, T2 and {1H}-15N nuclear Overhauser 
enhancement (NOE) [56] at 500 MHz and 600 MHz. Methyl bearing side-chain 
dynamics was extracted from 2H relaxation within CH2D isotopomers. IzCz, IzCzDz and 
IzCzDy relaxation experiments were collected at 500 and 600 MHz and analyzed as 
described previously [2].  
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4.3 Results and Discussion 
4.3.1 Crystal structures of apo and peptide-bound PDZ2. 
 
 In order to detect conformational changes resulting from peptide binding, 
crystallography was employed to determine structures of PDZ2 in the absence and 
presence of an 8-mer C-terminal peptide ligand from RA-GEF2 [147, 181]. Crystals in 
both forms diffracted X-rays to reasonably high resolution, 1.65 Å for apo PDZ2 and 1.3 
Å for RA-GEF2 bound PDZ2, respectively. The final R-factors for apo and peptide-
bound PDZ2 are 19.7% and 16.4% respectively (Table 4.2).  
Table 4.2: Structure refinement statistics 
 Apo PDZ2 RA-GEF2 PDZ2 
Resolution Range (Å) 39.6-1.6 29.7-1.3 
no. of reflections 133400 34191 
R-factor (%)a 19.7 16.4 
R-free (%)b 23.7 18.9 
no. of non-H atoms 4167 1040 
no. of water molecules 433 238 
Ramachandranc   
In most favoured regions 98.0 98.3 
In additional allowed 
regions 
2.0 1.7 
In disallowed regions 0.0 0.0 
a Rcryst = Σh ||Fobs| - |Fcalc||/Σh |Fobs|, where Fobs and Fcalc are the observed and calculated structure-factor amplitudes, 
respectively. 
b Rfree was calculated as Rcryst using approximately 5% of randomly selected unique reflections that were omitted 
from the structure refinement. Values in parentheses are for the highest resolution shell. 
c The Ramachandran analysis is performed using Molprobity. 
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Apo PDZ2 crystals belong to the P212121 space group. In the asymmetric unit, six 
monomers are packed to form two layers of three-blade propeller like structures 
  
Figure 4.1: Cartoon representation of PDZ2 crystal structures. Apo (A) and RA-GEF2 bound (B) PDZ2 
structures. Peptide is shown as stick model and electron density is shown as gray mesh. The density contour 
level is 1.5 σ. Peptide residues QVSAV have visible electron density. (C) RA-GEF2 and PDZ2 interaction 
network. RA-GEF2 peptide is shown by stick model and surrounding PDZ2 residues involved in peptide 
interaction are shown as lines. Bound water molecules involved in PDZ2 peptide interaction are shown as 
blue balls. The hydrogen bonds relevant to peptide binding are shown by yellow dotted lines. (D) Structural 
Superposition of apo (magenta) and RA-GEF2 bound PDZ2 (cyan). The RA-GEF2 peptide is shown by 
green stick model. All structural graphics were prepared using PyMOL.  
 
A B
C D
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(Fig. S4.1A and S4.1B). The average pair-wise Cα RMSD of the monomers is 0.18 Å, 
indicating all monomers are essentially identical. As expected, the crystal structure 
solved here conforms to the canonical PDZ domain fold, comprising 6 β-strands and 2 α-
helices (Fig. 4.1A). The second β-strand (β2) and the second α-helix (α2) constitute the 
peptide binding groove. The RA-GEF2:PDZ2 complex crystals belong to space group 
R32 (H32). One molecule appears in each asymmetric unit. A hexamer conformation (32 
symmetry), generated by crystallographic symmetry, is identical to the hexamer structure 
in the apo form. Based on calculation of the buried surface area in the hexamer interface 
by PISA [182], this PDZ domain molecule is expected to exist as a hexamer in solution; 
however, there is no evidence of this from NMR relaxation [2], which is sensitive to the 
rate of molecular tumbling, nor are higher-order oligomeric species evident from size 
exclusion chromatography. In the peptide-bound PDZ2 structure (Fig. 4.1B), hydrogen 
atoms were also modeled. In the RA-GEF2 peptide, the five C-terminal residues 
(QVSAV) show electron density. Using PDZ ligand numbering, counting backwards 
from the C-terminus, these are residues (0) to (-4). The RA-GEF2 peptide fitted into the 
binding groove forms an anti-parallel β-strand with protein strand β2. The interaction is 
further strengthened by packing of the most C-terminal valine side chain with the 
surrounding hydrophobic patch. The interaction is also stabilized by hydrogen bonding 
between Ser(-2) and the conserved H71 sidechain, as well as between the backbone of 
Ala(-1) and R79. In the apo state, the side chain of R79 adopts different conformations in 
the six different monomers. Upon binding peptide, this apparent flexibility is lost by 
hydrogen bonding to the carbonyl of Ala(-1). Consistent with previous studies, RA-GEF2 
residues back to (-4) are hydrogen bonded with the protein (Fig. 4.1C) [146]. In 
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establishing this intricate hydrogen bonding network, several bound water molecules are 
also involved (Fig. 4.1C). 
All atoms of apo and bound structures have very distinct electron densities, except 
side-chain atoms of loop residues S29-G33 and terminal residues Q93 and S94. 
Intriguingly, an irregular 310-helix is identified for residue fragment 30-33 (VRHGG), 
which is usually characterized as a partially structured loop in NMR structures or other 
PDZ2 homologues. Compared to the average temperature factor of the free protein (38 
Å2), high temperature factors (68 Å2 on average) are observed for this fragment, 
suggesting high flexibility. Even though B-factors are high, the backbone traces are very 
similar for all PDZ molecules. This fragment is also involved in crystal packing for both 
apo and peptide-bound PDZ2, as revealed by crystal lattice packing (Fig. S4.2). It is thus 
possible that the 310-helix of residues 30-34 is stabilized in part by the crystal lattice. 
Nevertheless, in PDZ domains from HtrA proteases, non-canonical helices have been 
observed in the intervening residues between β2 and β3 [183]. Furthermore, 13Cα 
chemical shifts are consistent with some degree of helicity in solution for residues 31-33 
(in both free and RA-GEF2 bound states), with an average (positive) deviation from 
random coil values of 1.6 ± 0.4 ppm. 
These high-resolution structures enable a new assessment of ligand induced 
conformational changes in PDZ2. As shown in Fig. 4.1D, no substantial conformational 
changes are observed: the Cα RMSD of apo and peptide-bound structures is 0.29 Å (0.21 
Å if loop residues 26-32 are excluded). This is reminiscent of peptide binding to PDZ3 of 
PSD95, for which no structural change was found [9], but distinct from the previously 
published NMR model of APC-bound mouse PDZ2, for which a 10° rotation of α2 was  
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reported [139]. The differences between the crystal structures and previously published 
PTP1E PDZ2 NMR structures are compared quantitatively in Table 4.3. The RMSDs 
between crystal and NMR structures range from 0.9 – 2.0 Å. Upon superposition of the 
apo and bound crystal structures here (excluding α2), RA-GEF2 binding induces a 
reorientation of α2 of only 2.8°. Thus, based on RMSDs, our crystal structures appear 
very similar to each other, yet show significant differences from the other PDZ structures. 
Significant discrepancies are also found among the NMR structures (Table 4.3), which 
are either human or mouse forms, even though human PDZ2 (3PDZ and 1D5G) [146, 
148] differs from mouse homologue (1GM1 and 1VJ6) [139, 147] by only 6 residues 
(including 2 conservative mutations). One possible source for these discrepancies is the 
different methodologies in structure determination. Despite the apparent high resolution, 
the crystal structures may be influenced by crystal packing effects that introduce 
structural artifacts and conformational trapping [184, 185]. Similarly, the NMR structures 
may suffer from inadequate NOE’s to fully define the structure in all regions. Thus a 
question arises: Are the crystal structures solved here good models for PDZ2 in solution? 
Table 4.3: RMSDs of published PTP1E PDZ2 structures and crystal structures 
RMSD (Å) b3LNX 3PDZ a1GM1 b3LNYRA-
GEF2 
1D5GRA-
GEF2 
a1VJ6APC 
b3LNX - 1.78c 0.85 0.29   
3PDZ 1.99 - 1.90  2.09  
a1GM1 0.98 2.28 -   1.39 
b3LNYRA-GEF2 0.30   - 1.32 1.21 
1D5GRA-GEF2  2.28  1.83 - 1.60 
a1VJ6APC   1.69 1.54 2.05 - 
a Mouse PTP PDZ2, which has 92% sequence identity to human PDZ2. 
b Crystal structures solved in this research. 
c The RMSD values above diagonal were calculated based on Cα structure alignments; values 
below the diagonal were calculated based on all heavy atoms.. 
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This prompted us to employ a solution-based approach, residual dipolar couplings (RDC), 
to further assess the crystal structures. 
4.3.2 Structure validation through solution RDCs.  
 
Residual dipolar couplings (RDCs) provide orientation information on internuclear 
vectors in biomolecules and are widely used in NMR structure calculations and domain-
domain docking [186]. Alternatively, solution RDCs can be used as a powerful tool to 
assess the quality of structural models generated without RDC information, which 
includes, for example, crystal structures. Similar to the R-factor in crystallography, a 
quality metric called the Q-factor is calculated by fitting experimental RDC data to a 
structural model [187]. The Q-factor varies between 0 and 1, with low Q values 
indicating high consistency between RDCs and the model, and high values indicating low 
consistency. Thus, high Q values (> 0.3-0.4) are generally suggestive of low structural 
quality, assuming that there are no problems/artifacts in the RDCs. Due to intrinsic errors 
in RDC data collection, the lower limit for Q-factors in practice is around 0.1 [188].  
To evaluate all deposited PDZ2 structures (none of which used RDCs in 
refinement), amide 1H-15N RDC data were collected for PDZ2 in apo, RA-GEF2 bound, 
and APC bound states. The crystal structures of apo and RA-GEF2 bound forms fitted to 
their respective RDCs yield low Q values of 0.22 and 0.21 respectively (Table 4.4). This 
good agreement suggests that the crystalline PDZ2 structures are not significantly 
affected by crystal packing and conformational trapping. By contrast, the NMR structures 
generate significantly higher Q values (from 0.39 to 0.82, Table 4.4). We note that many 
of the RDCs were also collected using lipid bicelles, and the Q-factors were very similar  
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Table 4.4: Q-factors calculated by fitting RDC data to structural models 
RDC datab Structurea
3LNX 3PDZ 1GM1 3LNYRA-
GEF2 
1D5GRA-
GEF2 
1VJ6APC 
Apo PDZ 0.22 0.82(0.82) 0.39(0.56) 0.29 - - 
PDZ2RA-GEF2 0.26 - - 0.21 0.67(0.71) 0.56(0.58) 
PDZ2APC 0.20 - - 0.23 0.81(0.77) 0.69(0.75) 
a The apo and RA-GEF2 bound PDZ2 structures solved here are 3LNX and 3LNY. For NMR 
structures, Q-factors were obtained by fitting against the best representative structure of the 
ensemble. Alternatively, RDCs were fit to bond vector orientations that represent averaging 
over the NMR ensemble (values in parentheses). All Q-factors were calculated using 
REDCAT.  
b Overlapping resonances were excluded in data fitting. To make Q-factors comparable, the 
same set of residues from each set of RDC data were selected to fit individual structures. The 
residues included in the fits are given in Table S4.3, and mapped on the RA-GEF2 bound 
crystal structure (Figure S4.4). 
 
 
 (data not shown). Overall, based on the computed Q-factors, the crystal structures 
reported here represent the average solution features of PDZ2 (apo or bound) 
significantly better than the existing NMR structures. We therefore expect that these 
crystal structures will provide more accurate coordinates for molecular dynamics 
simulation starting structures or structure-based studies of PDZ2.  
In addition, the RDC analysis suggests that an overall lack of change in the time-
averaged conformations of PDZ2 in response to peptide binding also holds true in 
solution. This is evident from the low Q-factors of 0.22 and 0.21 for apo and bound 
PDZ2 (Table 4.4). It is also evident upon considering that the apo PDZ2 RDCs are nearly 
as consistent with PDZ2RA-GEF2 structure as with apo PDZ2 (Q-factors of 0.29 versus 
0.22). Conversely, the PDZ2RA-GEF2 RDCs are nearly as consistent with the apo structure 
as with the PDZ2RA-GEF2 structure (Q-factors of 0.26 versus 0.21). These relatively small 
differences in Q-factors (0.05, 0.07) are suggestive of subtle structural and/or dynamic 
differences that exist between free and RA-GEF2 bound forms, although a significant 
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portion of the differences may be due to experimental uncertainty in the RDCs. It is 
interesting to note that RDCs from the APC-PDZ2 complex fit slightly better to apo-
PDZ2 than the RA-GEF2 bound structure (Table 4.4). We note that the Q-factor fitting 
included RDCs from α2 and β2 (Fig. S4.4), which form critical hydrogen bonds with 
peptide and should report on any structural change. The RDC data here appear to 
contradict a previous report of a 10º change in α2 orientation, in solution, upon binding 
the APC peptide [139]. However, that was carried out on mouse PDZ2, and it remains 
possible that mouse and human PDZ2s differ in this respect. We also note that there may 
be dynamic aspects to α2 in human PDZ2, as suggested from a slightly increased 15N R2 
at R79 relative to the other structured regions (in the apo form, data not shown). We 
speculate that α2 may undergo segmental motion on the ns-μs timescale. In summary, the 
RDC data are highly consistent with the crystal structures and show that neither RA-
GEF2 nor APC peptides induce significant conformational changes to human PDZ2 in 
solution. 
4.3.3 Long-range “pure” dynamic propagation in PDZ2 also results 
from APC peptide binding.  
 
In our previous study of the RA-GEF2 peptide binding to PDZ2 [2], binding was 
observed to perturb ps-ns dynamics of methyl-bearing side chains not only at the binding 
site, but also at two surfaces of PDZ2 distal to the peptide binding pocket. At that time, it 
was unclear to what extent the dynamic propagation was due to changes in peptide-
induced structural changes in PDZ2. The combined crystallographic and NMR results 
here strongly suggest that conformational change does not drive the dynamic changes and 
that PDZ2 channels the impact of peptide binding as a relatively “pure” dynamic 
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response to distal surfaces 1 and 2 [2]. The emerging picture appears to be that a network 
of residues extends through much of PDZ2. Atom fluctuations around mean positions of 
the network confer variable force patterns that can transmit perturbations over distances. 
We note that such behavior has recently been used as a perturbation-response tool in the 
context of molecular dynamics simulations [141, 142, 189, 190]. Thus, a major event 
such as peptide binding in the PDZ active site can alter fluctuation patterns well beyond 
the binding site without significant changes in mean structural positions. The patterns 
may in some cases manifest as correlated motions, as demonstrated recently for PDZ2 
[162]. This qualitative model is consistent with the ease of dynamic perturbation by both 
mutation and ligand binding [191].  
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Figure 4.2: Methyl-bearing side-chain dynamics changes (ΔS2axis) induced by RA-GEF2 (A) and APC (B) 
binding, with respect to free PDZ2. The methyl groups with significant changes in S2axis (ΔS2axis>2σ) are 
shown in filled bars. Fig 4.2A was adapted from Fuentes et al. [2] 
 
To further test this model and potentially increase confidence in the long-range 
dynamic propagation observed for RA-GEF2 binding, we characterized the methyl side-
chain dynamics of PDZ2 bound to a C-terminal peptide derived from the APC protein 
[192] using 2H relaxation. This peptide (GSYLVTSV) binds with Kd ~10 μM, similar to 
RA-GEF2 (Fig. S4.3). The changes in S2axis and τe upon APC peptide binding are very 
similar to those in RA-GEF2 (Fig. 4.2 for S2axis and Fig. S4.5 for τe). The patterns of 
changes in S2axis in PDZ2 upon binding either peptide are shown in Fig. 4.3. In the case of 
RA-GEF2 binding, propagation was previously observed out to “distal surfaces 1 and 2”, 
although distal surface 1 is less apparent in Fig. 4.3A because changes in τe are not shown.  
 
Figure 4.3: Graphical comparison of side-chain dynamic changes induced by RA-GEF2 (A) and APC 
binding (B). Red spheres represent residues experiencing significant (ΔS2axis>2σ) side-chain dynamic 
changes and peptide is shown as blue cartoon. The figures were prepared by PyMOL. 
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In the APC complex, only propagation to distal surface 1 is observed, but the pattern is 
near identical to that from RA-GEF2, both in terms of residues in the dynamic network 
and the magnitude of the dynamic response. One residue that shows a different response 
from the RA-GEF2 complex is at I6 at the N-terminal region of beta strand 1. 
Construction of a 2-way contingency table based on the presence or absence of 
significant ΔS2axis values in specific methyl groups in both complexes resulted in a high 
level of pattern matching, with the Fisher’s exact test p-value of 7.4 x 10-4 (Table 4.5).  
Table 4.5: Contingency table showing a correlation between APC and RA-GEF2 induced ΔS2axis
  RA-GEF2 
APC Significant Insignificant Total 
Significant 7 2 9 
Insignificant 4 25 29 
Total 11 27 38 
The p value based on Fisher’s exact test is 0.00074. 
 
This high degree of similarity in dynamic responses to RA-GEF2 and APC peptides 
demonstrates that the propagated dynamic responses are indeed real, reproducible, and 
more indicative of PDZ2 than ligand sequence (at least in these two cases). In addition, 
because the 1H-15N RDCs measured for APC-bound PDZ2 agree equally well with the 
crystal structure of RA-GEF2/PDZ2 (Q = 0.23, Table 4.4), these data also support pure 
dynamic propagation. We suggest that these data represent one of the best examples of 
dynamic propagation – or dynamic signal transduction [193] – detected experimentally 
and site-specifically, in the absence of conformational changes [145, 194, 195]. 
4.3.4 μs-ms timescale peptide binding dynamics.   
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A previous pre-steady state kinetic study of mouse PDZ2 binding to RA-GEF2 
peptide showed that peptide association proceeds through an induced-fit mechanism 
[139]. These kinetic data suggested that PDZ2 undergoes a ligand induced 
conformational change with kobs of ~7000 s-1. While the X-ray and RDC data presented 
above (on human PDZ2) do not support the existence of overall conformational change, it 
remains possible that conformational changes take place at low populations. To probe 
this possibility, we investigated μs-ms motions in PDZ2 using Carr-Purcell-Meiboom-
Gill (CPMG) relaxation dispersion methods [180]. In principle, this strategy allows 
monitoring of the kinetics (kex) and structural effects (as interpreted through the 
difference in chemical shift between states, ) of conformational events at the residue level 
and can detect minor populations as low as 0.5-1% [196]. 
Microsecond-millisecond timescale dynamics are frequently associated with 
conformational change, enzyme catalysis, and protein folding [197]. 15N CPMG 
relaxation dispersion experiments revealed that neither apo PDZ2 nor RA-GEF2 
saturated PDZ2 exhibit significant μs-ms motion (data not shown). However, for binding 
interactions of moderate strength (~micromolar), ligand binding and dissociation can 
occur on this timescale and are amenable to characterization by relaxation dispersion 
using sub-saturated complexes [198-201]. More specifically, there is the potential for 
identification of dynamic events that occur during binding. Of interest here, non-two-
state behavior was reported recently for peptide binding to the PDZ domain of AF-6, 
based on relaxation dispersion data [202]. To gain insight into the kinetics of binding and 
ligand specificity with site-specific resolution for PDZ2, 15N CPMG relaxation dispersion 
experiments were carried out on both RA-GEF2 and APC peptide complexes with 5% or 
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50% molar amounts of peptide. The lack of μs-ms exchange in the end states of the 
binding reaction is ideal for interpretation of line-broadening (i.e. relaxation dispersion) 
due to dynamic cycling of ligand binding and release. 
To bring the peptide binding kinetics into an exchange window suitable for 
characterization by CPMG relaxation dispersion, PDZ2 protein was mixed with 
substoichiometric amounts of peptide. For dispersion curve analysis, we employed two-
site exchange since the above structural studies indicated no evidence for conformational 
change. A two-site exchange binding process can be described by the following:  
2 2*on
off
k
k
PDZ peptide PDZ peptide⎯⎯→+ ←⎯⎯ ,     (eq. 3) 
where kon and koff are the on-rate and off-rate of peptide binding, respectively. The 
exchange rate (kex) is modulated by the free peptide concentration based on the following 
expression: 
[ ]ex on offk k peptide k= +  .       (eq. 4) 
Upon addition of 5% RA-GEF2 or APC peptide, relaxation dispersion was observed for 
residues along the binding groove and some distal regions. The high quality of the fits in 
Figure 4.4 is typical of the entire data sets for both peptide complexes. Local kex and Δω 
were fit assuming a fixed pA value of 0.95. Fits were carried out using the full Carver-
Richards equation, as well as the simplified form for fast exchange [180], and we report 
the parameters which yielded better agreement with Δω determined from titration. 
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Individually fitted exchange rates (kex), chemical shift changes (Δω) and intrinsic spin-
 
Figure 4.4: Two-state binding of RA-GEF2 and APC peptides based on 15N relaxation dispersion. 
Relaxation dispersion curves for select resonances in PDZ2 5% saturated with RA-GEF2 (A) and APC (B) 
peptides. Data acquired at 500 and 600 MHz (1H Larmor frequency) are shown in red and blue respectively. 
Data quality for these residues is typical of the entire dataset. In (C) and (D), correlation plots of 
fitted values from relaxation dispersion and 15N values from peptide titration. CPMG values are from global 
fits, as described in the main text. Data for RA-GEF2 and APC are in (C) and (D) respectively. The line is 
y = x.  
 
spin relaxation rates (R20) for PDZ2 residues in complex with RA-GEF2 and APC are 
provided in Tables 4.6 and 4.7, respectively. The distribution of kex values were quite 
uniform, with average kex values of 408 ±127 s-1 and 663±158 s-1 for PDZ2 bound to 5% 
RA-GEF2 or 5% APC peptides, respectively. Given the similarity of the locally fitted 
exchange rates, the data for each complex were globally fit to a model in which all 
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residues share the same exchange rate and population, but Δω and R20 are allowed to vary 
for each residue. The global fitting results are very similar to the local results (Table S4.1, 
S4.2). Importantly, globally fitted PA values were determined to be 94.7% and 94.5% for 
RA-GEF2 and APC, respectively, in excellent agreement with the predicted fraction of 
free protein (95%) based on measured Kd values and reactant concentrations. In addition, 
fitted Δω values (ΔωCPMG) for both peptides are remarkably consistent with the Δω values 
based on peptide titrations (Δωtitration) (Fig. 4.4C and 4D). This strongly suggests PDZ2 
samples two states (apo and fully bound) in the presence of peptide and these alone are 
responsible for dispersion. We note however, that there are a few resonances in each 
system for which we observe divergence between ΔωCPMG and Δωtitration. In the case of 
the APC complex, all of these outliers have very small Δω values. These discrepancies do 
not warrant further consideration since it is known that fitting relaxation dispersion with 
small chemical shift changes is error prone [203]. In the case of the RA-GEF2 complex, 
we find divergence for three residues with significant titration Δω values: G19, S21, and 
G34. Interestingly, G19 and S21 exhibit the smallest values of kex (255 and 204 s-1) in 
PDZ2. G19 and S21 are located at the binding pocket (in or near β2), and G34 lies at the 
end of the β2-β3 loop. Thus, although the majority of resonances in PDZ2 indicate simple 
two-state binding in the sensitivity regime for 15N CPMG relaxation dispersion, these few 
residues appear to hint at the existence of a RA-GEF2 binding intermediate localized to 
the vicinity of the peptide site. The behavior of G19, S21, and G34 is reminiscent of 
previously observed non-two-state behavior in ligand binding as observed from NMR 
relaxation dispersion [198, 200, 204]. The divergence from two-state behavior here 
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appears to be smaller than in those studies, yet larger than in the case of an SH3-ligand 
interaction [201]. Fits of the dispersion data to a 3-site exchange model was not carried  
out since this is advised only for when an abundance of dispersion curves is available 
[205]. 
Table 4.6: Local fitting results of 5% RA-GEF2 bound PDZ2 relaxation dispersion data
Residue kex (s-1) ΔωCPMG (ppm) aR20 (s-1) bR20 (s-1) cΔωtitration (ppm) 
17 385±40 0.93±0.02 9.96 ±0.09 10.46 ±0.10 0.92 
19 255±22 2.63±0.18 12.80 ±0.38 13.44 ±0.31 2.16 
20 357±21 1.56±0.04 10.39 ±0.14 11.37 ±0.13 1.59 
21 204±28 1.39±0.10 10.59 ±0.14 11.36 ±0.12 1.20 
22 478±369 0.48±0.08 14.69 ±0.26 14.41 ±0.22 0.28 
23 438±87 0.48±0.02 10.76 ±0.09 11.70 ±0.09 0.50 
24 336±98 0.57±0.04 12.49 ±0.19 12.67 ±0.18 0.50 
27 446±168 1.28±0.10 17.09 ±0.52 19.95 ±0.57 1.27 
31 432±154 0.78±0.08 19.42 ±0.45 20.70 ±0.38 0.71 
34 926±465 0.88±0.16 14.64 ±0.42 17.68 ±0.58 0.50 
35 480±48 0.95±0.03 12.72 ±0.14 13.88 ±0.16 0.92 
40 358±43 0.51±0.02 9.59 ±0.07 10.04 ±0.07 0.50 
45 440±39 0.74±0.02 10.43 ±0.10 11.11 ±0.10 0.71 
66 482±82 0.48±0.03 10.85 ±0.08 11.49 ±0.09 0.43 
67 348±29 0.54±0.01 9.83 ±0.05 10.53 ±0.05 0.52 
70 434±29 0.92±0.02 11.17 ±0.10 11.67 ±0.10 0.93 
71 386±67 0.48±0.02 12.94 ±0.10 13.38 ±0.09 0.36 
72 319±33 1.26±0.04 10.90 ±0.13 11.19 ±0.12 1.28 
74 448±20 0.92±0.01 10.07 ±0.07 10.65 ±0.07 0.96 
75 412±19 0.79±0.01 10.53 ±0.05 10.98 ±0.06 0.81 
76 326±32 0.88±0.02 10.06 ±0.08 11.10 ±0.08 0.85 
79 285±10 2.64±0.08 11.19 ±0.16 11.84 ±0.15 2.55 
80 407±27 0.78±0.02 9.43 ±0.08 9.85 ±0.09 0.82 
81 445±44 0.48±0.02 7.79 ±0.05 7.83 ±0.05 0.36 
82 394±109 0.57±0.04 14.01 ±0.17 13.67 ±0.16 0.52 
86 384±73 0.44±0.02 10.73 ±0.07 11.30 ±0.08 0.35 
a Values at 500 MHz. b Values at 600 MHz. c 15N Δωtitration values were calculated as the difference between apo and 
RA-GEF2 saturated PDZ2.
 
The primarily two-state relaxation dispersion behavior reported here contrasts with 
the CPMG-derived ligand binding dynamics in the AF-6 PDZ domain, which showed 
extensive discrepancies between ΔωCPMG and Δωtitration and hence is suggestive of an 
intermediate state during the binding process [202]. However, in the AF-6 PDZ, the apo 
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protein samples different conformations on the millisecond timescale, which complicates 
the interpretation of peptide binding dynamics. In the sub-saturated complexes of PDZ2,  
Table 4.7: Local fitting results of 5% APC bound PDZ2 relaxation dispersion data
Residue kex (s-1) ΔωCPMG (ppm) aR20 (s-1) bR20 (s-1) c Δωtitration (ppm) 
11 480 ±54 0.46 ±0.02 10.07 ±0.04 10.52 ±0.05 0.54 
17 690 ±25 1.14 ±0.02 9.84 ±0.08 10.28 ±0.09 1.10 
19 550 ±110 2.37 ±0.16 12.16 ±0.41 13.4 ±0.5 2.26 
20 640 ±30 1.22 ±0.02 10.48 ±0.1 11.4 ±0.12 1.19 
21 620 ±36 1.09 ±0.02 10.71 ±0.1 11.17 ±0.15 1.20 
22 610 ±92 0.84 ±0.04 14.02 ±0.16 14.24 ±0.21 0.77 
23 570 ±50 0.64 ±0.02 11.39 ±0.06 11.79 ±0.07 0.57 
24 765 ±65 1.51 ±0.05 12.47 ±0.23 11.86 ±0.3 1.53 
25 960 ±260 1.54 ±0.15 13.32 ±0.61 13.01 ±0.92 1.52 
27 720 ±130 1.50 ±0.09 16.89 ±0.46 18.78 ±0.66 1.49 
28 710 ± 270 0.66 ±0.09 16.61 ±0.25 18.23 ±0.31 0.52 
31 620 ±140 0.94 ±0.07 19.2 ±0.28 21.09 ±0.41 0.88 
34 1280 ±580 0.76 ±0.15 15.49 ±0.26 18.32 ±0.4 0.35 
35 610 ±47 0.92 ±0.02 13.16 ±0.11 14.26 ±0.14 0.82 
45 610 ±46 0.79 ±0.02 10.67 ±0.07 11.24 ±0.09 0.72 
46 510 ±57 0.60 ±0.02 10.36 ±0.07 10.87 ±0.09 0.59 
54 660 ±56 0.51 ±0.02 10.94 ±0.05 11.19 ±0.06 0.44 
66 490 ±70 0.50 ±0.03 11.34 ±0.07 11.6 ±0.08 0.48 
70 690 ±33 1.05 ±0.02 11.2 ±0.08 11.56 ±0.11 0.96 
72 620 ±29 1.07 ±0.02 10.75 ±0.08 11.03 ±0.1 1.06 
74 570 ±20 0.83 ±0.01 10.38 ±0.04 10.8 ±0.05 0.79 
76 680 ±26 1.26 ±0.02 10.33 ±0.09 10.73 ±0.1 1.28 
78 650 ±69 0.59 ±0.02 10.54 ±0.06 11.06 ±0.07 0.49 
79 690 ±59 2.59 ±0.06 10.6 ±0.19 10.86 ±0.24 2.72 
80 619 ±23 1.05 ±0.01 9.71 ±0.06 9.86 ±0.08 0.98 
81 616 ±46 0.57 ±0.02 7.52 ±0.04 8.05 ±0.06 0.50 
a Values at 500 MHz. b Values at 600 MHz. c 15N Δωtitration values were calculated as the difference between apo and 
RA-GEF2 saturated PDZ2.
 
chemical exchange only arises from peptide binding dynamics, leading to tight 
correlations between ΔωCPMG and Δωtitration (Figure 4.4C,D). As some PDZ domains are 
known to change their shape [14, 119], future studies of apo dynamics and ligand binding 
dynamics on the μs-ms timescale should help to determine how common alternative 
conformational states in PDZ domains are. 
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For clean two-site exchange, it is reasonable to expect the on-rate for peptide 
binding (kon) to approach the diffusion limit. To test this, we calculated kon and koff from 
the dependence of kex on peptide concentration. To this end, an additional set of 
relaxation dispersion data were collected with 50% RA-GEF2. The higher ligand 
concentration pushed exchange rates into the intermediate regime and hence many 
resonances disappeared. Nevertheless, enough relaxation dispersion curves were obtained 
to perform global fitting (Table 4.8). Solving the two linear equations (eq. 4) at the two  
Table 4.8: Global fitting results of 50% RA-GEF2 bound PDZ2 relaxation 
dispersion data 
Residue kex (s-1) ΔωCPMG 
(ppm) 
 [PA] (%) 
aR20 (s-1) cΔωtitration (ppm) 
11 554±42 0.40±0.03 56.5±0.13 10±0.13 0.38 
17 554±42 0.89±0.03 56.5±0.13 0.48±0.04 0.92 
23 554±42 0.92±0.07 56.5±0.13 12.38±0.56 0.50 
35 554±42 0.98±0.02 56.5±0.13 0.46±0.03 0.92 
39 554±42 0.30±0.03 56.5±0.13 11.19±0.12 0.27 
66 554±42 0.99±0.05 56.5±0.13 nc 0.43 
74 554±42 0.25±n 56.5±0.13 nc 0.96 
a Values for 500 MHz field. b The experimental δωs were calculated from apo and RA-GEF2 saturated 
PDZ2. c No reasonable fitting values can be obtained. 
 
peptide concentrations (using globally determined kex), the on-rate was determined to be 
3.6×107 s-1M-1, which is approaching the diffusion limit, and the off-rate is 307 s-1, which 
is very similar to the previously reported value, 270±20 s-1.[139].  
4.4 Summary  
 
Taken together, the X-ray and NMR results reported here on RA-GEF2 and APC 
peptides are inconsistent with an induced-fit or conformational selection mechanism of 
binding to PDZ2, and highly consistent with binding via “lock-and-key”. No significant 
changes in PDZ2 coordinates are observed between the apo and RA-GEF2 peptide bound 
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crystal structures, which is supported further by 1H-15N RDCs. The absence of significant 
CPMG relaxation dispersion for apo (or peptide bound) PDZ2 is consistent with lack of 
conformational change in the crystal structures. We note, however, that a caveat of the 
relaxation dispersion experiments is that processes faster than ~100 μs are not detected 
and hence sampling of intermediate binding states on a timescale faster than this cannot 
be excluded. In the context of this “rigid” PDZ2 domain, binding of both RA-GEF2 and 
APC peptides induce very similar patterns of changes in ps-ns side-chain dynamic 
fluctuations that propagate away from the binding site, forming apparent allosteric 
pathways. Thus, the primary physical impact of peptide binding to PDZ2 is dynamic and 
not structural in nature. This has implications for understanding the physical basis for 
long-range communication and allostery in proteins. 
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Appendices 
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Figure S2.1: Solvent accessibility analysis by NMR. (A) SEA-HSQC spectrum of PDZ3. Only solvent 
exposed amides yield intense peaks in the SEA-HSQC spectrum (compare with normal HSQC in Fig 1A). 
(B) Correlation plot of PDZ3 and phosphoPDZ3 SEA-HSQC intensities. Only the residues which are 
minimally perturbed by phosphorylation (the ones have CPS < 0.05 ppm in Fig. 2A) are selected to make 
the plot. The scaling factor of 0.74 was obtained from the slope of the line. (C) The solvent accessibility 
changes by phosphorylation with reference to PDZ3 were plotted onto PDZ3 crystal structure using color 
scale. The Y397 was shown in stick model.  
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Table S4.1: Global fitting results of 5% RA-GEF2 bound PDZ2 relaxation dispersion data 
Residue kex (s-1) ΔωCPMG 
(ppm) 
 [PA] (%) 
aR20 (s-1) bR20 (s-1) cΔωtitration 
(ppm) 
17 320.53±11.79 0.97±0.03 94.7±0.2 9.99±0.11 10.55±0.1 0.92 
19 320.53±11.79 2.32±0.20 94.7±0.2 12.75±0.56 13.29±0.42 2.16 
20 320.53±11.79 1.67±0.06 94.7±0.2 10.38±0.18 11.41±0.14 1.59 
21 320.53±11.79 1.15±0.04 94.7±0.2 10.61±0.17 11.3±0.14 1.20 
22 320.53±11.79 0.43±0.12 94.7±0.2 14.74±0.31 14.5±0.21 0.28 
23 320.53±11.79 0.48±0.03 94.7±0.2 10.79±0.1 11.74±0.1 0.50 
24 320.53±11.79 0.60±0.06 94.7±0.2 12.45±0.25 12.66±0.2 0.50 
27 320.53±11.79 1.33±0.14 94.7±0.2 17.17±0.64 20.12±0.53 1.27 
31 320.53±11.79 0.87±0.11 94.7±0.2 19.32±0.54 20.61±0.41 0.71 
34 320.53±11.79 0.77±0.09 94.7±0.2 15.11±0.29 18.21±0.41 0.50 
35 320.53±11.79 1.10±0.05 94.7±0.2 12.73±0.19 13.98±0.18 0.92 
40 320.53±11.79 0.54±0.02 94.7±0.2 9.59±0.09 10.06±0.08 0.50 
45 320.53±11.79 0.80±0.03 94.7±0.2 10.45±0.12 11.19±0.11 0.71 
66 320.53±11.79 0.48±0.03 94.7±0.2 10.9±0.1 11.54±0.1 0.43 
67 320.53±11.79 0.58±0.02 94.7±0.2 9.82±0.06 10.53±0.05 0.52 
70 320.53±11.79 1.07±0.04 94.7±0.2 11.1±0.14 11.69±0.12 0.93 
71 320.53±11.79 0.50±0.03 94.7±0.2 12.95±0.12 13.38±0.1 0.36 
72 320.53±11.79 1.29±0.05 94.7±0.2 10.91±0.16 11.18±0.13 1.28 
74 320.53±11.79 1.06±0.03 94.7±0.2 10.05±0.08 10.69±0.09 0.96 
75 320.53±11.79 0.88±0.02 94.7±0.2 10.52±0.07 11.02±0.07 0.81 
76 320.53±11.79 0.90±0.03 94.7±0.2 10.05±0.1 11.1±0.08 0.85 
79 320.53±11.79 2.52±0.10 94.7±0.2 11.22±0.21 11.81±0.19 2.55 
80 320.53±11.79 0.86±0.03 94.7±0.2 9.4±0.09 9.88±0.09 0.82 
81 320.53±11.79 0.49±0.03 94.7±0.2 7.78±0.07 7.87±0.06 0.36 
82 320.53±11.79 0.59±0.05 94.7±0.2 14.03±0.22 13.72±0.18 0.52 
86 320.53±11.79 0.46±0.03 94.7±0.2 10.72±0.09 11.32±0.08 0.35 
a Values at 500 MHz. b Values at 600 MHz. c The experimental Δωtitration values were calculated as the difference 
between apo and RA-GEF2 saturated PDZ2.  
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Table S4.2: Global fitting results of 5% APC bound PDZ2 relaxation dispersion data 
Residue kex (s-1) ΔωCPMG (ppm)  [PA] (%) aR20 (s-1) bR20 (s-1) cΔωtitration 
(ppm) 
11 534 ±17 0.452 ±0.02 94.5 ±0.3 10.05 ±0.06 10.49 ±0.07 0.54 
17 534 ±17 1.146 ±0.037 94.5 ±0.3 9.88 ±0.09 10.41 ±0.09 1.10 
19 534 ±17 2.184 ±0.143 94.5 ±0.3 12.23 ±0.49 13.86 ±0.48 2.26 
20 534 ±17 1.255 ±0.04 94.5 ±0.3 10.44 ±0.11 11.43 ±0.13 1.19 
23 534 ±17 0.624 ±0.023 94.5 ±0.3 11.38 ±0.07 11.78 ±0.08 0.57 
24 534 ±17 1.591 ±0.076 94.5 ±0.3 12.5 ±0.27 12.05 ±0.32 1.53 
27 534 ±17 1.585 ±0.124 94.5 ±0.3 16.88 ±0.54 18.98 ±0.59 1.49 
28 534 ±17 0.589 ±0.065 94.5 ±0.3 16.67 ±0.25 18.34 ±0.33 0.52 
31 534 ±17 0.925 ±0.077 94.5 ±0.3 19.23 ±0.37 21.18 ±0.42 0.88 
35 534 ±17 0.904 ±0.032 94.5 ±0.3 13.18 ±0.11 14.3 ±0.13 0.82 
45 534 ±17 0.767 ±0.024 94.5 ±0.3 10.68 ±0.09 11.28 ±0.1 0.72 
54 534 ±17 0.478 ±0.019 94.5 ±0.3 10.96 ±0.06 11.24 ±0.06 0.44 
66 534 ±17 0.495 ±0.024 94.5 ±0.3 11.35 ±0.08 11.57 ±0.08 0.48 
70 534 ±17 1.03 ±0.031 94.5 ±0.3 11.25 ±0.09 11.71 ±0.1 0.96 
74 534 ±17 0.822 ±0.023 94.5 ±0.3 10.34 ±0.06 10.8 ±0.06 0.79 
76 534 ±17 1.293 ±0.042 94.5 ±0.3 10.33 ±0.1 10.82 ±0.11 1.28 
78 534 ±17 0.551 ±0.02 94.5 ±0.3 10.58 ±0.07 11.11 ±0.08 0.49 
79 534 ±17 2.604 ±0.142 94.5 ±0.3 10.91 ±0.25 11.73 ±0.24 2.72 
81 534 ±17 0.534 ±0.016 94.5 ±0.3 7.55 ±0.05 8.11 ±0.05 0.50 
a Values at 500 MHz. b Values at 600 MHz. c The experimental Δωtitration values were calculated as the difference 
between apo and APC saturated PDZ2.  
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Table S4.3.  Residues for which RDCs values were used in 
Q-factor calculations. 
Apo PDZ2 RA-GEF2 bound APC bound 
7 6 7 
8 7 8 
10 8 10 
11 9 11 
12 10 12 
15 11 14 
16 12 16 
17 14 17 
22 15 19 
23 16 22 
24 17 23 
26 19 24 
27 21 25 
31 23 26 
33 24 27 
34 26 28 
36 27 29 
37 28 30 
38 29 31 
39 30 33 
47 31 34 
48 34 35 
49 37 37 
50 38 38 
51 40 39 
56 41 43 
57 43 44 
58 44 45 
59 45 46 
62 47 47 
63 48 48 
66 49 49 
67 51 50 
69 52 51 
70 54 52 
71 55 54 
72 56 55 
73 57 56 
74 59 58 
76 61 61 
78 62 62 
79 63 63 
80 64 64 
81 65 65 
85 66 66 
87 67 67 
88 69 69 
89 70 70 
90 71 71 
93 72 72 
74 73 
76 74 
77 76 
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79 77 
80 78
81 79 
82 80 
86 81 
87 85 
88 87 
89 88 
90 89 
91 90 
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Figure S4.1: Crystal packing within the asymmetric unit for apo PDZ2. (A) top view of the asymmetric unit. 
The six monomers are colored red, green and blue, and three-blade propeller organization is found. (B) side 
view of the asymmetric unit. Two layers of three-blade propellers are visible. The figure was prepared 
using PyMOL. 
 
 
Figure S4.2: Involvement of residue 30-33 in crystal packing. (A) Apo PDZ2 crystal packing. An arbitrary 
asymmetric unit (colored as red) which contains six apo PDZ2 monomers is selected and six surrounding 
asymmetric units are also displayed. The fragment 30-33 is shown as stick model and colored the same for 
the fragment belonging to the same asymmetric unit. (B) RA-GEF2 bound PDZ2 crystal packing. Six 
molecules belonging to six different adjacent asymmetric units are shown. For clarity, fragment 30-33 was 
shown as stick and colored differently (red or green) for neighboring molecules. The figure was prepared 
using PyMOL. 
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Figure S4.3: Determination of KD for PDZ2-APC peptide interaction by NMR titration. 1H-15N HSQC 
spectra were acquired at increasing APC:PDZ ratios until no further peak shifts were observed. Only data 
for the backbone amide at Ile20 are shown, but KD values for the other reporters are within 10%. The 
ordinate axis contains the reduced chemical shift difference ( ) between free and APC　　 -bound PDZ as 
determined from HSQC spectra. The data were then fit to the standard quadratic equation for binding. The 
apparent irregularities in the fitted/theoretical line are due to changes in PDZ2 concentration during the 
titration.   
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Figure S4.4: Distribution of residues used in calculation of Q-factors (shown in Table 4). Residues for 
which 1H-15N RDC values were used for fitting to structural models are shown in blue on PDZ2. RDC sets 
are for apo PDZ2 (A), RA-GEF2 bound PDZ2 (B), and APC bound PDZ2. Secondary structural units in 
PDZ2 are indicated. 
 
A    B    C 
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Figure S4.5: Internal correlation time (τe) changes induced by RA-GEF2 and APC binding with respect to 
free PDZ2.  
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